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ABSTRACT: The H4IIE cell bioassay has proven utility as a screening tool for planar halo-
genated hydrocarbons (PHHs) and structurally similar chemicals accumulated in organisms from
the wild. This bioassay has additional applications in hazard assessment of PHH exposed popu-
lations. In this review, the toxicological principles, current protocols, performance criteria, and
field applications for the assay are described. The H4IIE cell bioassay has several advantages over
the analytical measurement of PHHs in environmental samples, but conclusions from studies can
be strengthened when both bioassay and analytical chemistry data are presented together. Often,
the bioassay results concur with biological effects in organisms and support direct measures of
PHHs. For biomonitoring purposes and prioritization of PHH-contaminated environments, the
H4IIE bioassay may be faster and less expensive than analytical measurements. The H4IIE cell
bioassay can be used in combination with other biomarkers such as in vivo measurements of
CYP1A1 induction to help pinpoint the sources and identities of dioxin-like chemicals. The num-
ber of studies that measure H4IIE-derived TCDD-EQs continues to increase, resulting in subtle
improvements over time. Further experiments are required to determine if TCDD-EQs derived
from mammalian cells are adequate predictors of toxicity to non-mammalian species. The H4IIE
cell bioassay has been used in over 300 published studies, and its combination of speed, simplicity,
and ability to integrate the effects of complex contaminant mixtures makes it a valuable addition
to hazard assessment and biomonitoring studies.
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I. INTRODUCTION
A. Background
Planar halogenated hydrocarbons (PHHs) are
structurally similar chemicals that typically refer to
polychlorinated biphenyls (PCBs), polychlorinated
dibenzo-p-dioxins (PCDDs), and polychlorinated
dibenzofurans (PCDFs). PHHs originate from in-
dustrial activities or as unwanted by-products of
chemical synthesis or combustion; (Hutzinger et al.,
1974; Metcalfe and Haffner, 1995; Rappe et al.,
1987; Safe, 1994). Accordingly, PHHs have been
released into the environment both intentionally
and inadvertently. These contaminants can enter
the environment through both point sources and
atmospheric deposition, and have been detected
at various trophic levels in aquatic and terrestrial
ecosystems. Concerns surround PHH contamina-
tion of the environment due to their inherent tox-
icity and strong tendency to bioaccumulate in fish
(Muir et al., 1985) as well as through the aquatic
food chain to wildlife and humans (Borgmann
and Whittle, 1991; Hellou et al., 1993; van den
Heuvel and Lucier, 1993). Despite declining en-
vironmental concentrations of some PHHs during
the 1980s (Schmitt et al., 1999), PHHs are continu-
ally released from waste incineration facilities, con-
taminated sediments, and derelict PCB-containing
equipment. Although structurally and chemically
similar, PHHs vary greatly in toxicity (Grimwood
and Dobbs, 1995). The current degree of PHH con-
tamination at certain locations in the environment
is still above concentrations that are considered a
threat to human and wildlife health.
B. PHH Structure and Toxicity
The toxicity of PHHs is dependent on their
structure, with the most toxic compound be-
ing 2,3,7,8-tetrachlorodibenzo-p-dioxin or TCDD
(Poland et al., 1979; Poland and Bradfield, 1992;
Nebert et al., 1993; Okey et al., 1994). A number
of common toxic responses are observed in labora-
tory animals exposed to PHHs. These include loss of
body weight, thymic atrophy, immunotoxicity, hep-
atotoxicity, chloracne, and other dermal lesions (re-
viewed in Safe, 1990). Many biochemical changes
are also observed in animals and cells in culture
exposed to PHHs. A common biochemical indica-
tor of PHH exposure is the induction of a number
of specific “drug-metabolizing” enzymes including
cytochrome P-450 1A1 and 1A2, and four non-P-
450 proteins (Nebert et al., 2000). The correlation
between the degree of this enzyme induction by
individual PHH congeners and their relative toxic
potencies in animals led to the development of a
receptor-mediated model to describe the mechanism
of action for PHHs (Poland et al., 1976, 1979). Cur-
rent understanding of PHH toxicity indicates that
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TCDD or structurally similar compounds enter a
living cell and bind to a cytosolic protein, the aryl
hydrocarbon receptor (AhR). The AhR–ligand com-
plex translocates into the nucleus and acts as a tran-
scription factor for specific dioxin-responsive ele-
ments (DREs). Genes associated with these DREs
increase in expression and include the previously
mentioned drug-metabolizing enzymes (Whitlock,
1999; Nebert et al., 2000). The exact mechanistic
relationships between gene expression and toxicity
is still unknown. Toxicity of PHHs through AhR-
independent mechanisms likely also exists (Hoffer
et al., 1996; Peters et al., 1999), but strong corre-
lations between AhR-mediated events and toxicity
suggest that this pathway plays the most significant
role in the effects of PHH exposure. The mecha-
nism of AhR signal transduction and that of gene
expression are believed to operate similarly in all
vertebrates (Hahn et al., 1998).
The relationship between PHH structure and
toxicity is the basis of toxic equivalency factors
(TEFs) and the toxic equivalents (TEQ)∗ approach
(Safe et al., 1986; Safe, 1990, 1999; van den Berg
et al., 1998; Sanderson and van den Berg, 1999;
Birnbaum, 1999; Tillitt, 1999). The TEQ approach
is used to determine the toxic potency of complex
PHH mixtures in the environment. Assuming a simi-
lar mechanism of action for all PHHs, the potency of
each chemical in a mixture to cause a particular toxic
or biological effect can be expressed as a fraction
of the potency of TCDD (the most potent PHH) to
cause the same effect. Based on a variety of biolog-
ical endpoints, “relative potency factors” or RPFs
are assigned to different PHHs (van den Berg et al.,
1998). All RPFs for an individual PHH are evalu-
ated to derive a consensus value that describes an
order-of-magnitude toxic potency for that PHH, its
toxic equivalency factor (TEF; van den Berg et al.,
1998). The toxic potency of PHHs in a sample from
the environment is estimated by the multiplication
of the concentrations of individual PHHs by their
respective TEFs and summed to yield a final TEQ.
RPFs based on long-term in vivo studies of toxic
effects are given more weight in the derivation of a
TEF than short-term in vitro studies of biochemical
responses.
∗The standard notation of TEQs will be used when
we discuss toxic potency derived from chemical concen-
trations and TEF/RPF values. Throughout the text we will
use TCDD-EQs to designate toxic potency estimates de-
rived from the H4IIE bioassay.
C. Induction Potency Versus Toxic
Potency
It should be stressed that TEQs derived from
CYP1A1 induction assays estimate the toxic po-
tency of a chemical mixture based on the relation-
ship between induction of this enzyme and in vivo
toxic effects. Induction of CYP1A1 alone does not
constitute a toxic effect per se, but likely occurs
in parallel with disruption of other biological pro-
cesses. Studies by Safe and coworkers (Safe et al.,
1986; Safe, 1990) demonstrated rank-order correla-
tions between biochemical measurements in H4IIE
cells (e.g., enzyme induction, receptor binding) and
whole-animal effects. This suggested that cell cul-
ture systems could be used as a rapid, inexpensive
tool to estimate the toxic potency of PHHs and their
mixtures. One of the fundamental assumptions un-
derlying the H4IIE cell bioassay is that PHHs exert
their effects through a similar characterized mech-
anism of action. Although literally thousands of re-
search papers have been published on the responses
of vertebrates to PHHs, we still lack true knowledge
of the exact biochemical pathways that are altered
by exposure to these chemicals (Tillitt, 1999; Nebert
et al., 2000). It is unclear if gene products induced
by AhR ligands are responsible for toxic outcomes
or simply correlated to them. The vast number of or-
gan systems and physiological processes that PHHs
affect suggests that AhR-mediated responses are not
the only pathway to toxicity (Enan and Matsumura,
1995). These limitations, while they do create uncer-
tainty, are of a theoretical nature and do not neces-
sarily limit the predictive benefits that the H4IIE cell
bioassay can provide. The relationship between acti-
vation of the AhR gene battery (including CYP1A1)
and adverse toxicological outcomes is well docu-
mented, supporting the use of the H4IIE cell bioas-
say in the development of TEQs and TCDD-EQs.
D. Cultured Cells as Model Systems
The use of cultured cells as model systems to
investigate mechanisms of PHH toxicity and predict
adverse effects offers many advantages in terms of
cost and speed over in vivo studies. Cultured cells
have been used for decades in toxicology to study
important biochemical events and pathways re-
lated to environmental contaminant exposure (Rees,
1980; Bols et al., 1985). Cell lines responsive to
PHH exposure allow rapid development of RPFs
used for ranking the toxic potency environmen-
tal samples and in the development of TEFs. The
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most widely used biochemical indicator of the
presence of PHHs is cytochrome P-4501A1, or
CYP1A1 induction. Induction of CYP1A1 (mea-
sured as aryl hydrocarbon hydroxylase, or AHH,
activity) in mammalian cell culture (hamster fe-
tus cells) was first reported by Nebert and Gelboin
(1968a). Since that time, a number of cell cul-
ture bioassays have been used to determine RPFs
of individual chemicals and extracts from environ-
mental samples relative to TCDD. These include
mammalian (Hammond and Strobel, 1992), fish
(Hightower and Renfro, 1988; Lee et al., 1993;
Jung et al., 2001), and avian (Kennedy et al., 1993)
cultured cells. RPFs are derived by comparing the
activity of AHH or ethoxyresorufin O-deethylase
(EROD, another catalytic measure of CYP1A1) in
cells exposed to PHHs or chemical mixtures to the
activity in TCDD exposed cells. These RPFs are
then used to support TEF development or estimate
the toxic potency of environmental extracts.
E. The H4IIE Cell Line
Benedict et al. (1973) reported that an ideal
cell line for examining PHH potency was the H4IIE
rat hepatoma cell line due to its excellent growth
properties and low basal AHH activity. The H4IIE
cell line was derived from Reuber Hepatoma H-35
(Reuber, 1961) by Pitot et al. (1964). The H4IIE
cells have low basal CYP1A1 activity along with a
high degree of responsiveness towards PHHs. The
net result is an observed 20- to over 100-fold in-
duction above basal CYP1A1 enzyme activity in
the H4IIE cells after PHH exposure. The extreme
potency of TCDD as a CYP1A1 inducer in H4IIE
was demonstrated by Niwa et al. (1975). Based on
their findings, the authors suggested that H4IIE cells
could be used in a bioassay for the detection of
minute (10−14 mol) amounts of TCDD. Bradlaw and
Casterline (1979) first described the use of H4IIE
cells to screen for the presence of planar polychlo-
rinated organic compounds in foods prior to ana-
lytical identification. The authors reported the rela-
tive AHH-inducing potency in H4IIE of 24 PCDDs,
11 PCDFs, 7 PCBs, and extracts from several food
sources. This was the first use of H4IIE as a tool to
rank the potency of PHHs, an idea first proposed by
Poland and Glover (1973).
The relationship between the induction of
CYP1A1 in H4IIE and in vivo toxicity was exam-
ined extensively by Safe and coworkers in the 1980s
(Bandiera et al., 1984; Safe et al., 1986; Mason
et al., 1986). These studies demonstrated that for
PCDD and PCDF congeners, comparable structure–
activity relationships (SARs) were observed using
the H4IIE cell bioassay (AHH and EROD induc-
tion), in vitro AhR receptor binding assays, and in
vivo responses in immature male Wistar rats (hepatic
EROD and AHH activity, thymic atrophy, and body
weight loss). Significant linear relationships were
observed between the −log EC50 (H4IIE AHH in-
duction) of 8 PCB, 5 PCDD, and 15 PCDF con-
geners versus −log ED50 for body weight loss
(r = .93) and thymic atrophy (r = .92; Safe, 1987).
Similarity in CYP1A1 induction patterns in vivo
and in vitro was demonstrated by Yu et al. (1996),
supporting the use of the H4IIE cell bioassay as a
tool to predict CYP1A1 induction potential. Radi-
olabeled PCB 77 was used to compare the induc-
tion of CYP1A1 in dosed H4IIE cells and rat livers.
The enzyme induction pattern was similar in both
in vivo and in vitro systems. Radioactivity of PCB
77 and EROD activity were significantly correlated
(r2 = .985) when compared on an equivalent weight
basis for both systems. This study was an important
contribution to the validation of the in vitro assay
with in vivo data. These results support the use and
development of the H4IIE cell bioassay as a practi-
cal, short-term test to quantitatively predict the po-
tential toxicity of a sample containing PHHs and
structurally similar compounds.
The H4IIE cell bioassay is not very effective
for assessment of potential toxicity of PAHs in or-
ganisms. This is true for the same reasons that rou-
tine analytical measurement of PAHs are not very
effective for estimation of chronic exposure or ef-
fects of PAHs. Large hydrophobic PAHs can be AhR
active, but they are easily metabolized in part due
to their lack of halogenation (Nebert et al., 1993).
As a result, PAHs do not bioaccumulate substan-
tially in vertebrates, or at least not to the predicted
amounts based on physical properties such as Kow
(Schnitz and O’Connor, 1992). Thus, measures of
PAH exposure in vertebrates, including the H4IIE
cell bioassay, underestimate the potential toxicity of
PAHs and other AhR ligands that are readily metab-
olized and excreted. Examples of this phenomenon
have been published: Rainbow trout (Oncorhynchus
mykiss) exposed to PAH (creosote)-contaminated
water displayed a dose-dependent increase in hep-
atic EROD (in vivo), but both H4IIE TCDD-EQs and
measured PAHs in tissue extracts did not differ from
reference tissue extracts (Whyte et al., 2000). Cer-
tain naturally occurring PAHs such as 7-isopropyl-
1-methylphenanthrene (retene) can be enriched in
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sediments, like those downstream of some pulp
and paper mills, and have demonstrated CYP1A-
inducing activity (Fragoso et al., 1999). Retene is
believed to be a contributor to in vivo CYP1A in-
duction and toxicity (Basu et al., 2001), yet it would
not contribute to TCDD-EQs due to its metabolic
elimination.
The absence of the PAHs in biological extracts
does not mean that these chemicals have not caused
an adverse effect in the organism, only that they are
too short-lived to be accurately measured. Detec-
tion of rapidly metabolized contaminants is not a
challenge unique to the H4IIE cell bioassay. Chem-
ical analysis of PAHs in vertebrates is similarly
not an effective measure of chronic exposure to
organisms. However, the H4IIE bioassay will re-
spond to any AhR ligand if it is present in the ma-
trix of interest. This makes the bioassay a useful
tool for detection of PAHs in abiotic matrices (e.g.,
sediments; Jones et al., 1993a; Hoke et al., 1994;
Hilscherova et al., 2000) or biotic matrices where
metabolism is not expected to be significant (e.g.,
molluscs; McDonald et al., 1994; Kennicutt et al.,
1995). However, interpretation of H4IIE bioassay
results from abiotic matrices (soil, sediment, fly ash,
etc.) may not be possible. The individual chemicals
(PAHs or other AhR ligands) have unique physic-
ochemical properties of transport and transforma-
tion in the environment. Therefore, it is impossi-
ble to predict the exposure of an organisms based
on the single potency value that results from the
H4IIE cell bioassay of an abiotic matrix, such as
soil or sediment. The complex processes of chem-
ical fate are chemical specific. The single potency
value does not provide distinction of which specific
chemicals are present and exert the given potency
in the sediment or soil. Chemical-specific rates of
sorption, desorption, bioconcentration, metabolism,
distribution, and so on are required to determine
the overall rates of transfer of specific chemicals
from an abiotic portion of the environment to an or-
ganism (i.e., sediment to fish). Therefore, although
it is tempting to screen sediments or other abiotic
matrices with the H4IIE bioassay, it is not a rec-
ommended practice without simultaneous chemi-
cal characterization. The complementary chemical
analysis, in this situation, may drastically reduce
the need and/or benefit of the H4IIE cell bioas-
say. The presence of PHHs and PAHs occurring to-
gether as mixtures complicates the hazard or risk
assessment process. For instance, high concentra-
tions of PAHs in sediment extracts containing PHHs
can result in atypical dose-response behavior in
the H4IIE cell bioassay, making data interpreta-
tion difficult even with complete characterization
(Gale et al., 2000). Fractionation techniques allow
the isolation or removal of specific chemicals in
extracts, enabling determination of the contribu-
tion of different classes of chemicals to CYP1A
induction (Gale et al., 2000). Isolation of PHHs
in biological samples can be accomplished using
sulfuric acid silica gel during extract preparation
to destroy (oxidize) nonchlorinated PAHs (Tillitt
et al., 1991; Oikari et al., 2002). Using fractionation
methods, the identities of the most active CYP1A-
inducing classes of compounds in an extract can be
determined.
To summarize, the use of the H4IIE bioassay to
make predictions about the risk associated with PAH
exposure is not justified at present (Till et al., 1999).
This does not, however, decrease the utility of the
H4IIE bioassay to screen for the presence of AhR
ligands in environmental samples, whether these are
PHHs, PAHs, or a complex mixture. It only under-
scores the need to exercise care when using H4IIE
cell bioassay result for hazard assessment purposes
when significant amounts of PAHs are present in the
samples. Currently, the H4IIE cell bioassay is bet-
ter suited for toxicity identification procedures for
detecting PAH contamination in nonbiological ma-
trices or in organisms where metabolism does not
influence PAH concentrations.
An important advantage of the H4IIE cell bioas-
say over analytical chemistry techniques is that it
estimates the sum concentration of biologically ac-
tive chemicals in an extract based on their respec-
tive potencies as CYP1A1 inducers. Analytical tech-
niques such as gas chromatography can indicate
the presence of different chemical entities, but by
themselves cannot describe the differences in toxi-
city among chemicals or how these chemicals exert
their effects as a mixture. As described previously,
researchers use TEFs as an additive index to ex-
press the total toxic potential of mixtures of PHHs
(Sawyer and Safe, 1985; Eadon et al., 1986; van
den Berg et al., 1998). This is reasonable based
on the similar mode of action of PHHs; however,
there are important uncertainties associated with this
approach. Foremost is the possibility of nonaddi-
tive interactions among PHHs leading to erroneous
predictions of greater or lesser toxic potency of a
mixture. Reported PHH interactions include antag-
onism (Bannister et al., 1987; Aarts et al., 1995) or
synergism (Bannister and Safe, 1987). The H4IIE
cell bioassay can be used to address this potential
problem by estimating the overall potency of a
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chemical extract. The same technique for RPF
development is used, but rather than comparing
CYP1A1 induction by individual PHHs to that of
TCDD, cells are exposed to an entire chemical
extract. The ratio of the CYP1A1 induction by the
extract to that of TCDD is expressed as a TCDD
equivalent concentration (TCDD-EQ, pg/g). The
assumption of additivity in the TEF model can
be tested by comparing the TCDD-EQ of an ex-
tract to the TEQ for the same extract generated us-
ing RPFs and analytical chemistry data. Deviations
from equality of these two values may indicate non-
additive interactions among chemicals in the mix-
ture tested. The estimation of TCDD-EQs in envi-
ronmental samples using the H4IIE cell bioassay
has been used extensively to quantitatively express
the toxic potency of PHHs and related chemicals
accumulated in organisms and their habitat.
The objectives of this review are to describe the
development and utility of the H4IIE cell bioassay as
a tool for estimating the presence and toxic potency
of PHHs and related compounds in wildlife and
other environmental samples. A discussion of the
capabilities of the bioassay is balanced with cautions
regarding its limitations. Also included in this dis-
cussion are methods to avoid some of these potential
pitfalls. An extensive review of the past and current
literature allows the reader to evaluate the contribu-
tions of the H4IIE cell bioassay to biomonitoring
efforts and hazard assessment. In the first section,
a detailed analysis of current protocols, character-
ization, experimental conditions, and performance
criteria of the H4IIE cell bioassay is described. This
is followed by an appraisal of the H4IIE cell bioas-
say as a screening tool for environmental contam-
inants. The third section of this review examines
the use of H4IIE-derived TCDD-EQs in hazard as-
sessment. Finally, recent techniques derived from
the H4IIE cell bioassay (e.g., H4IIE cell lines trans-
fected with AhR-responsive reporter genes) will be
compared to the original bioassay. Other in vitro
methods of estimating PHH concentrations in envi-
ronmental samples exist (Roberts and Durst, 1995;
Zajicek et al., 2000), but comparisons of these tech-
niques with the H4IIE cell bioassay are beyond the
scope of our review. The goal of this review is to
provide the reader with an understanding of how
and why the H4IIE cell bioassay has been used.
This will, in turn, help scientists more effectively
incorporate this tool into studies on environmental
contamination by PHHs. Additionally, we hope this
review serves as the foundation or platform from
which study results from the H4IIE bioassay may
be interpreted.
II. H4IIE CELL BIOASSAY
PROTOCOL
The H4IIE cell bioassay has undergone many
changes since its first use as a tool for measuring the
dioxin-like activity of chemical extracts from envi-
ronmental samples. This section reviews the current
general procedures for the assay (Figure 1). The gen-
eral steps include: (1) preparation of the chemical
to be tested or chemical extraction; (2) H4IIE cell
culture; (3) plating of cultured cells; (4) dosing of
H4IIE cells with chemicals and TCDD standards
and incubation; and (5) determination of CYP1A1
activity and data analysis. Certain laboratories may
use slightly modified versions of the protocol de-
scribed here due to equipment availability and per-
sonal preference (Table 1). For instance, the use of
multiwell microtiter plates for cell dosing and con-
ducting the EROD assay has become popular with
the increased availability of plate-reading fluorome-
ters, but some researchers perform the assay in petri
plates. This review focuses on what are considered
to be the most up-to-date techniques, but includes
references to previously used techniques as well.
A. Chemical Extract Preparation
The initial step in using the H4IIE bioassay
to estimate chemical concentrations and determine
their toxic potency is to isolate specific chemicals
of interest and transfer them to a suitable carrier
solvent for dosing. Chemicals can be standards pur-
chased from chemical supply companies or analytes
extracted from environmental samples (e.g., tissue
or sediment). In the case of the H4IIE cell bioas-
say, chemicals that bind to the AhR (i.e., dioxin-
like PHHs) are the targets of interest. The H4IIE
cell bioassay is typically used to analyze chemical
extracts of tissue or sediment, but extracts of air
particulates (Franze´n et al., 1988), lipid-containing
semipermeable membrane devices (Lebo et al.,
1995), and water (Murk et al., 1996) have also been
analyzed with H4IIE cells.
Sample extraction and cleanup can follow any
one of a number of techniques that are appropriate
for PHHs. Environmental samples should be stored
frozen at −20◦C before the extraction process is
initiated to provide protection for the target ana-
lytes (Huestis et al., 1995; McFarland et al., 1995).
Samples are homogenized and dried with sodium
sulfate prior to extraction. Extractions can be made
with a number of organic solvents, by column, Soxh-
let, or dialysis methods (Hale and Greaves, 1992;
6
FIGURE 1. Graphic summary of the H4IIE cell line bioassay procedure. Refer to text for detailed
description of individual stages of the procedure.
Meadows et al., 1993; Huestis et al., 1995). We rou-
tinely use column extraction with methylene chlo-
ride. Lipids are removed from the extract by gel per-
meation chromatography or acid digestion methods
(Schwartz and Lehmann, 1982; Hale and Greaves,
1992; Huestis et al., 1995). Lipid removal by gel
permeation is a nondestructive method based on
size exclusion chromatography (Ribick et al., 1981).
This is an additional procedure in sample process-
ing, but it is essential to remove lipids, which can
alter the partitioning of chemicals to the cells in
the bioassay procedure. Alternatively, a faster and
less expensive method of lipid removal is through
acidification of the sample. The acid is introduced
to the sample by impregnation of an adsorbent, sil-
ica gel. Acidic silica gel can be placed at the bot-
tom of the extraction column and lipid removal oc-
curs at the same time as extraction (Schwartz and
Lehmann, 1982). Internal standards are not gen-
erally added to samples that are to be tested with
the H4IIE bioassay because the standards may have
measurable dioxin-like activity or alter the response
of the mixture being tested (Gale et al., 2000). The
lack of internal recovery standards is a limitation of
the general protocols for testing environmental sam-
ples with the H4IIE bioassay. Low recoveries may
go undetected, even with external recovery sam-
ples in the quality assurance set. Splits of the ex-
tracts that are to undergo instrumental analysis can
be spiked with internal standards at this point. By
using different fractionation techniques, chemical
extracts containing specific classes of contaminants
can be prepared and tested with the H4IIE bioassay
(Figure 2).
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FIGURE 2. Environmental extract fractionation scheme. After gel permeation chromatography, the
whole extract (F1) is split. One portion is eluted from potassium silicate (KS), then separated by
argentate chromatography into PHH-only (F2) and PAH-only (F3) fractions. Another portion is se-
quentially eluted from sulfuric acid–silica gel (SASG) and SASG/KS/silica gel (F4) and separated
by carbon column chromatography into non-ortho (F5), mono-ortho (F6), and bulk PCB (F7), and,
after basic alumina, a PCDD/PCDF fraction (F8). PCB fractions (F5, F6, and F7) are recombined
as F9 for H4IIE cell bioassay. From Gale et al. (2000).
The hydrophobic solvents used in the extrac-
tion process such as hexane and methylene chloride
are toxic to H4IIE cells. To eliminate this solvent-
related toxicity in the bioassay, extracted contam-
inants are transferred from the extraction solvents
into a suitable carrier solvent that is less toxic to
the H4IIE cells. The most commonly used car-
rier solvents are isooctane and dimethyl sulfox-
ide (DMSO). In the initial paper describing the
H4IIE bioassay as a potential screening tool, Brad-
law and Casterline (1979) initially exposed cells
to chemicals dissolved in DMSO and water. The
potency of TCDD to induce AHH activity was in-
creased by using isooctane as the carrier solvent,
and thus the experimental procedure was changed
so that isooctane was used exclusively in subse-
quent experiments. In contrast to this, Clemons et al.
(1994) observed that maximum EROD activity was
fourfold greater in cells that received TCDD dis-
solved in DMSO versus the same concentration
of TCDD delivered in isooctane. This observation
was supported by Yu et al. (1997); H4IIE cells ex-
posed to 3,3′,4,4′-tetrachlorobiphenyl (PCB 77) in
DMSO had higher EROD activity than cells that re-
ceived the same dose of PCB 77 dissolved in isooc-
tane. Tillitt et al. (1991a) reported that isooctane
gave optimal response and sensitivity as a solvent
carrier.
DMSO mixes readily with cell culture medium
and increases cell membrane permeability, and con-
sequently the potential for chemicals to be delivered
to the cell (Sanderson et al., 1998). The alteration
of membrane permeability by DMSO has been a
concern of some researchers (Tillitt et al., 1991a).
Cell membrane permeability and the control of os-
motic processes are integrally related to a variety of
physiological processes of normal cellular home-
ostasis (Sperelakis, 2001). Thus, alteration in cell
permeability by DMSO may have unexpected or
unpredictable effects on the responsiveness of the
H4IIE cells. DMSO alters the transcriptional and
translational activities of CYP1A in cultured cells
(Lindsay et al., 1990). Isooctane has minimal sol-
ubility in the culture, and forms a thin film at the
top of the media. As the isooctane evaporates and
diffuses into the media, PHHs will also be allowed
to diffuse into the media and cells. An advantage
of isooctane is its lower cytotoxicity compared to
DMSO. The effect of chemical exposure time on the
potency and efficacy of TCDD and PCB 77 in avian
primary hepatocytes was much less when isooctane
was used as a carrier solvent as compared to DMSO
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(Sanderson et al., 1998). For instance, the potency
of PCB 77 decreased 10- to 20-fold when measured
at 48 h as compared to 24 h. With isooctane, the
difference over the same time period was less than
2-fold. More research is needed to determine if po-
tency differences observed in avian systems are as
great in mammalian systems and how this should
affect carrier solvent selection. Isooctane has advan-
tages over DMSO in that it is compatible with most
chemical residue analysis techniques for PHHs and
is less expensive than DMSO. Isooctane also has
greater consistency among lots of solvent. Finally,
DMSO may contain AhR ligands (M. Denison, Uni-
versity of California, Davis, personal communica-
tion). Regardless of which solvent is used in the
H4IIE cell bioassay, solvent controls should be run
with each batch/plate. Solvent controls should not
have induction over the basal level of EROD activ-
ity in H4IIE, nor should the carrier solvent inhibit
the induction of CYP1A1 in the cells. Over time,
significant changes in EROD activity measured in
solvent control wells/plates may indicate contami-
nation of carrier solvent stock. If contamination is
suspected, solvent should be replaced with a fresh
lot and new chemical standards should be prepared
using this new solvent.
B. H4IIE Cell Culture
Routinely performing the H4IIE bioassay re-
quires a stable, consistent source of cells. Initial
aliquots of cryopreserved H4IIE cells can be ob-
tained from the American Type Culture Collection
(ATCC number CRL-1548). These aliquots are free
of Mycoplasma arginini, a common biological con-
taminant in cell cultures. Mycoplasma contamina-
tion may cause adverse effects, such as changes in
metabolism, growth, viability, DNA, RNA, and pro-
tein synthesis; and morphology (Freshney, 1992).
Thus, it is important to ensure that H4IIE cultures
are free of mycoplasma contamination in order to
avoid unreliable experiment results. Instructions for
subculture are based on Bradlaw et al. (1979) and
culturing notes are listed in Table 2.
H4IIE cells can be easily cultured on a rou-
tine basis with the proper equipment and nutritional
components for mammalian cell growth. Cells re-
quire a defined growth medium, a suitable growth
environment, and routine care. Two recipes for
growth media are described in Table 2. These media
provide the nutritional, hormonal, and stromal fac-
tors necessary for H4IIE cell growth. Although most
of the components of the H4IIE medium are chemi-
cally defined, the addition of 10–15% bovine serum
may lead to batch variation in media. Serum is a
complex mixture of small and large biomolecules
with physiologically balanced growth-promoting
and growth-inhibiting activities (Freshney, 1992).
Although much is known about the nutritional role
of the components in serum, there remain numer-
ous factors whose physiological roles are not fully
understood.
The influence of serum on the results of the
H4IIE cell bioassay has not been fully explored to
date. The high degree of precision among labora-
tories for this bioassay (see next section) indicates
that serum is not a source of great variability when
H4IIE cells are used in this specific manner. How-
ever, the concentration of serum used in cultur-
ing H4IIE cells has been reported to influence
the metabolism of drugs such as ibuprofen by cy-
tochrome P-450 enzymes (Menzel-Soglowek et al.,
1992). Higher levels of EROD activity are main-
tained in primary rat hepatocytes cultured in serum-
free medium, although there is a selective decline
in P-450 activities and toxicity with increased time
in culture (Hammond and Fry, 1992). Studies such
as these indicate the potential for serum-related
variation in CYP1A1 activity in H4IIE. The ef-
fect of serum on CYP1A1 induction has been ex-
plored in fish cell culture (Hestermann et al., 2000).
These authors used the PLHC-1 hepatic tumor cell
line derived from the translucent topminnow (Poe-
ciliopsis lucida) and performed their experiments
nearly identically to the H4IIE cell bioassay proce-
dures (Hightower and Renfro, 1988). They found
the presence of 10% calf serum in the PLHC-1
medium resulted in reduced relative potencies for
TCDD, PCBs 77, 3,3′,4,4′,5-pentachlorobiphenyl
(PCB 126), and 3,3′,4,4′,5,5′-hexachlorobiphenyl
(PCB 169) as compared to cells exposed in serum-
free medium (Hestermann et al., 2000). Using ra-
diolabeled TCDD, it was determined that the in the
presence of serum, the bioavailability of TCDD is
reduced so that less chemical can enter the cells.
This finding highlights the importance of using
a constant serum concentration when performing
the H4IIE cell bioassay or when comparing results
among laboratories. Potential variability due to the
presence of serum could be eliminated by expos-
ing H4IIE cells to contaminants in the absence of
serum, and only using serum-containing medium
during routine culturing. This technique has been
used in relatively few studies. Alternatively, the de-
velopment of a serum-free medium (i.e., a fully
chemically defined medium) specifically for H4IIE
would lead to a highly standardized culture and
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TABLE 2
Culturing Properties for H4IIE Rat Hepatoma Cells
Property Description
ATCC number CRL-1548
Organism Rat (Rattus norvegicus)
Tissue Hepatoma; liver
Morphology Epithelial
Growth properties Adherent
Subculturinga Remove medium, add fresh 0.25% trypsin solution for 1 to 3 min, remove trypsin
and let the culture sit at 37◦C for 10 to 15 min. Add fresh medium, aspirate and
dispense into new flasks.
Split ratioa A subcultivation ratio of 1:2 to 1:4 is recommended.
Fluid renewala Every 2 to 3 days.
Media for propagation ATCC medium: minimum essential medium (Eagle) in Earle’s basic salt solution
with 80% nonessential amino acids, 10% fetal bovine serum, 10% bovine calf
serum.
Tillitt Medium (Tillitt et al., 1991a): Dulbecco’s modified Eagle’s medium, 2 ×
nonessential amino acids, 1.5 × nonessential amino acids, 1 mM pyruvate,
1000 mg/L D-glucose, 2200 mg/L sodium bicarbonate, 15% fetal bovine serum.
Growth environment 75-cm2 Polystyrene flasks in a 37◦C humidified, 5% CO2 environment.
Culture duration Initiate new culture from frozen cells after approximately 10 passages to reduce
risk of intraspecies cross-contamination, phenotypic drift, or senescence
(Freshney, 1992).
aAs described by ATCC—http://www.atcc.org/
dosing environment. However, the use of serum-free
media in the H4IIE cell bioassay will likely not be
standard practice in the foreseeable future. Draw-
backs of serum-free media include greater expense,
slower cell growth, and the need for a more strict
physicochemical environment than cultures grown
in serum-containing media (Freshney, 1992). As
mentioned previously, the precision reported among
laboratories using the H4IIE cell bioassay does not
indicate that serum is a significant source of varia-
tion, and for this reason serum will likely continue
to be used routinely. Determination of the poten-
tial influence of serum on results in the H4IIE cell
bioassay would be valuable.
The physical environment for H4IIE cell
growth is similar to that for most mammalian cell
lines. Cells are maintained in a humidified incu-
bator at 37◦C in a 5% CO2 atmosphere (Tillitt
et al., 1991a), and are typically grown in 75-cm2
polystyrene flasks. Under these conditions, H4IIE
cells proliferate rapidly. Subcultivation, or “split-
ting,” of the cell culture is performed on confluent
flasks every 4–5 days. In addition to subcultivation,
ATCC recommends replacing the medium in the
culture flasks with fresh medium every 2–3 days
to ensure that the nutritional requirements of the
cells are being met. Tillitt et al. (1991a) recommend
beginning new H4IIE cultures after nine subcultiva-
tions or less to reduce the risk of phenotypic drift,
transformation, or senescence in the population.
C. Plating
The H4IIE cells are grown and exposed to
chemicals or contaminant extracts in tissue culture
plates. This ensures proper replication of samples
and allows for increased numbers of samples to be
tested. In the original H4IIE cell line bioassay, cell
monolayers were grown in 60- to 100-mm-diameter
petri plates or in smaller culture flasks (e.g., 25 cm2)
prior to dosing (Bradlaw et al., 1980; Sawyer and
Safe, 1982; Bannister et al., 1987). Multi-well mi-
crotiter plates are more commonly used in cur-
rent investigations (Tysklind et al., 1994; Sanderson
et al., 1996; Whyte et al., 1998). Plates with 48 or
96 wells have several advantages over single petri
plates. Microtiter plates allow many replicates to
be tested on the same plate while occupying rel-
atively little space in incubators. The smaller size
of the wells means that fewer cells are plated and
less media is expended in the plating process. From
a safety and disposal standpoint, much lower dos-
ing volumes of contaminants can be used compared
to larger petri plates while still achieving the same
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exposure concentration. Probably the single greatest
advantage of using multiwell plates is the time sav-
ings of the EROD assay in multiwell plate-reading
fluorometers (Tysklind et al., 1994; Kennedy and
Jones, 1994; also see Section E). These instruments
determine the degree of CYP1A1 catalytic activ-
ity in all the wells of an entire plate typically in a
minute or less. This type of automation greatly in-
creases sample throughput and eliminates much of
the variability associated with manual determination
of CYP1A1 catalytic activity.
Whether petri plates or multiwell plates are
used, steps should be taken to ensure that equal num-
bers of cells are added to each plate or well in an
experiment. Cell protein is measured to normalize
CYP1A1 catalytic estimates among wells (see Sec-
tion E), but equal plating density of cells is the best
way to reduce variability in a multiwell assay. The
growth characteristics of the cells will be consistent
when grown at the same density, and the chemi-
cal exposure of the cells will be consistent among
wells or plates. H4IIE cells are harvested from cell
culture flasks with the aid of trypsin and cell scrap-
ers and resuspended in medium to form a single
cell suspension (Honeycutt et al., 1996; Khim et al.,
2000). Estimates of cell concentration can be made
with a hemocytometer and used to calculate the re-
quired cell seeding density. The H4IIE cells may
be centrifuged at low speeds (100–500 × g) and
resuspended in media if the cell density needs to
be increased. This can be done without harm to the
cells. The medium volume and seeding density are
dependent on the surface area of the form of petri
dish or multiwell plate used (Table 1). H4IIE cells
are generally incubated for 24 h prior to dosing to
allow cell attachment to the chamber surface (Tillitt
et al., 1991a).
D. Dosing and Incubation
H4IIE cells receive a dilution series of the
chemical or extract of interest in carrier solvent
for determination of a RPF or TCDD-EQ. TCDD
standard solutions can be purchased from commer-
cial suppliers (e.g., Accustandard, New Haven, CT;
Ultra Scientific, North Kingstown, RI). The number
of doses that cells are exposed to typically ranges
from 6 to greater than 10 doses prepared at be-
tween 3- and 10-fold serial dilution factors. Con-
centrations of extract at various dilutions can be
expressed in terms of gram equivalents [tissue or
sediment mass extracted (g) · solvent carrier vol-
ume (µL)−1 · dilution factor−1]. When possible, a
wide range (3 to 4 orders of magnitude) of doses
should be used for chemical extracts, where pa-
rameters such as maximal CYP1A1 induction and
slope are unknown. Accurate TCDD-EQ determi-
nation requires that the number of extract doses
cover the full CYP1A1 induction range in H4IIE
(Figure 3A). An ED50 cannot be calculated without
knowing the maximal induction of CYP1A activity
caused by a compound or extract. Often this is not
known ahead of time. Techniques for dealing with
incomplete dose-response curves are discussed in
Section F, Data Analysis. Dosing of cells seeded in
FIGURE 3. (A) Complete dose-response
curve of chemically induced CYP1A1 in-
duction and estimated chemical ED50. (B)
Incomplete dose-response curve of chemically
induced CYP1A1 induction demonstrating
both indeterminate maximal induction and
chemical ED50. A complete dose-response
curve provides the greatest confidence in
estimating ED50.
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multiwell culture plates allows for a greater range
of doses than petri plates.
Dosing of H4IIE cells is performed under a
laminar flow hood using aseptic technique as with
routine culturing. Although exposure duration is
typically only 72 h, effort should be made to
eliminate any influence of bacterial or fungal con-
tamination. Doses of test chemical (2.5–100 µl de-
pending on volume of growth medium) are adminis-
tered to cells using micropipettes with either plastic
(polyethylene) or glass pipette tips. The hydropho-
bic nature of PHHs has brought into question the
use of polyethylene pipette tips. Although no pub-
lished studies have specifically examined adsorption
of PHHs onto polyethylene tips, other hydropho-
bic chemicals have been observed to bind to plastic
pipette tips (Upton et al., 1987; Hyenstrand et al.,
2001). Hyenstrand (2001) reported that delivery of
a solution of the hydrophobic cyanobacterial toxin
microcystin-LR with plastic disposable pipette tips
resulted in a loss of 4.2% per tip operation. Using
the same pipette tip, four operations were required
to completely saturate a single tip with toxin. This
indicates that there is the potential for loss of chem-
ical during dosing of H4IIE cells if plastic tips are
used, and that this loss would not be uniform if indi-
vidual pipette tips were used more than once. Pos-
itive displacement pipettes with stainless steel pis-
tons and glass capillary tubes have been used when
dosing H4IIE cells to reduce chemical adsorption
(Clemons et al., 1998; Whyte et al., 1998). Rins-
ing the pipette piston with solvent between differ-
ent chemicals used for dosing is required. However,
it is not practical to routinely use single, positive-
displacement pipettes for large-scale use of the
H4IIE bioassay such as the Biomonitoring of En-
vironmental Status and Trends (BEST) fish health
monitoring efforts (Whyte and Tillitt, 2000). Multi-
channel pipettes allow simultaneous dosing of wells
in multi-well plates: A dilution series of a chemical
extract in conical vials is placed in an appropriate
sized rack to accommodate the use of the multichan-
nel pipette. Following dosing, vials can be capped
and stored for later use.
Isooctane or DMSO are commonly used as
chemical carrier solvents in the H4IIE bioassay as
mentioned previously. It has been suggested that the
amount of carrier solvent used should not exceed
0.5% of the total solution to eliminate interference or
toxicity due to the presence of excess carrier solvent
(Bradlaw and Casterline, 1979; Harris et al., 1989).
Trivedi et al. (1990) examined the toxicity of DMSO
to the human carcinoma cell line HeLa. When
the initial number of cells plated was 3 × 104/ml,
DMSO concentration of 1% or less had no apparent
effect on the rate of proliferation for up to 48 h of
incubation at 37◦C. In incubations up to 72 h, cell
growth was repressed by 1% DMSO. At higher cell
plating density (3 × 105/ml), the effect of DMSO
was similar. The effect of other carrier solvents on
proliferation of H4IIE cells has not been examined
to our knowledge, but Tillitt et al. (1991a) reported
no effect of dosing volume on EROD induction in
H4IIE at isooctane concentrations between 0.1%
and 1.5% of the total volume with incubation for
72 h. This indicates that the commonly used solvent
concentration of 0.5% isooctane should not inter-
fere with the H4IIE cell bioassay, but investigations
specifically examining the effects of isooctane or
DMSO concentrations on H4IIE cell growth and vi-
ability are needed.
Dosed H4IIE cells are incubated for between
24 and 72 h, with the 72-h duration being the
most widely used. Incubation time can influence
CYP1A1 induction in H4IIE, and this influence is
chemical specific. For TCDD, a range of exposure
times between 6 and 72 h had no effect on EROD
induction EC50s (Clemons et al., 1997). Incuba-
tion time did, however, influence EC50s for 2,3,7,8-
tetrachlorodibenzofuran (2,3,7,8-TCDF; increase of
approximately 9-fold) and PCB 77 (increase of ap-
proximately 11-fold) as incubation time increased
from 6 to 72 h. It was hypothesized that the shift in
EC50 was due to metabolism of the parent com-
pound during incubation (Clemons et al., 1997).
Parrott et al. (2000) reported that H4IIE incuba-
tion time greatly affected the potency of liver ex-
tracts from white sucker (Catostomus commersoni)
exposed to bleached-kraft mill effluent (BKME).
Cells exposed to extract for periods greater than 24 h
showed decreasing EROD activity with time, again
suggesting that cells were able to metabolize some
of the CYP1A1 inducing components in the extract
(Parrott et al., 2000).
The studies just described indicate that a stan-
dard incubation time for chemicals or extracts
should be set for the H4IIE cell bioassay when de-
termining extract potency or developing RPFs. The
length of exposure should allow for maximal induc-
tion of CYP1A1, but not be so long that significant
metabolism of inducing compounds takes place.
The metabolism of certain inducing chemicals may
provide more realism when comparing results from
the in vitro assay to in vivo experiments, but in situa-
tions where the H4IIE cell bioassay is used solely to
estimate the concentration of inducing chemicals in
environmental extracts, this metabolism is an inter-
ference that should be avoided. An exposure period
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of 24 h appears to reduce the influence of chemical
metabolism, but the majority of published studies
using the H4IIE cell bioassay use 72 h as a stan-
dard incubation period. Study results would likely
not be affected by the metabolism of AhR-active
compounds in an extract. This is true because most
studies have used acidified extraction procedures to
remove labile compounds. It does, however, appear
that an in-depth study of the effects of exposure time
in the H4IIE cell bioassay should be conducted to
determine the optimal duration for chemical stabil-
ity and maximal CYP1A1 induction.
E. Measurement of CYP1A1
Catalytic Activity (AHH or EROD)
Determination of CYP1A1 catalytic activity in
chemically exposed H4IIE cells was originally de-
scribed by Bradlaw and Casterline (1979) and was
based on Nebert and Gelboin’s (1968b) original
method of measuring AHH activity in mammalian
cell culture. In recent years, researchers almost ex-
clusively measure EROD activity as the catalytic
endpoint for CYP1A1 measurement in the H4IIE
cell bioassay for reasons described in the next para-
graph. However, a large amount of highly useful
and foundational information came from the mea-
surement of AHH in H4IIE cells. The AHH as-
say of CYP1A1 activity measures the conversion of
benzo[a]pyrene (BaP) to 3-hydroxybenzo[a]pyrene
(Figure 1) and serves as a functional indicator of
the amount of CYP1A1 present in the reaction mix-
ture. This reaction requires both the reduced form
of nicotinamide-dinucleotide phosphate (NADPH)
and molecular oxygen. The assay is initiated af-
ter the chemical or extract exposure period by re-
moving the overlying medium from the H4IIE cells
and rinsing them with a buffer such as phosphate
buffered saline (pH 7.4). At this point, aseptic tech-
nique is no longer necessary and the assay can be
performed on the benchtop (this is also true for the
EROD assay; see later discussion). Cells are har-
vested by trypsinization, scraping, or a combination
of both (Bradlaw and Casterline, 1979; Sawyer and
Safe, 1982). A cellular protein pellet produced after
centrifugation (e.g., 10,000 × g for 5 min) is resus-
pended in buffer. AHH activity can be measured
(Sawyer and Safe, 1982) or the resuspended pellet
can be further centrifuged (105,000 × g for 60 min)
to isolate the microsomal fraction where the P-450
enzymes reside (Nebert and Gelboin, 1968b). The
enzymatic activity of AHH is usually measured flu-
orometrically. The cell homogenate or microsomal
fraction is combined with buffer, NADPH, MgCl2,
and benzo[a]pyrene (Table 3). The reaction is car-
ried out for 15–30 min at 37◦C and is terminated
with the addition of a acetone:methanol mixture
(Bradlaw and Casterline, 1979; Pa¨ivi et al., 1992). A
portion of the organic extract is then extracted with
1 N NaOH (Sawyer and Safe, 1982) and the fluores-
cence of this fraction is measured at 396 nm exci-
tation and 517 nm emission. Protein determination
can be carried out before or after measurement of
3-hydroxybenzo[a]pyrene using the method of
Lowry (1951) or Bradford (1976). If protein is mea-
sured before the assay, a defined amount of cellular
homogenate is used in the reaction (e.g., 0.1 mg/ml).
Measurement of protein allows standardization of
3-hydroxybenzo[a]pyrene fluorescence to protein
content. AHH activity is expressed in units of
picomoles 3-hydroxybenzo[a]pyrene formed per
milligram of cellular protein per minute of the assay
duration (pmol/mg/min).
TABLE 3
Example Reaction Components for Determination of Aryl Hydrocarbon Hydroxylase (AHH)
in the H4IIE Cell Bioassay
Assay reagent Bradlaw and Casterline (1979) Sawyer and Safe (1982) Pa¨ivi et al. (1992)
Buffer Tris-chloride Tris-sucrose Potassium phosphate
50 mM, pH 7.5 0.015–0.075 M, pH 8.0 25 mM , pH 7.5
MgCl2 3.0 mM 2.34 mM 3.6 mM
NADPH 0.36 mM 0.28 mM 0.36 mM
NADH Not added 0.33 mM 0.42 mM
Albumin Not added 540 µg 675 µg
Benzo[a]pyrene 80 µM in methanol 1.98 µM 80 µM in acetone
Final volume 1 ml 1 ml 1 ml
Assay temperature 37◦C 37◦C 37◦C
Incubation time 30 min 15 min 15 min
15
Determination of EROD activity in the H4IIE
cell bioassay became more common in the mid-
1980s due to the increased safety, decreased cost,
and greater efficiency compared to the AHH as-
say. The EROD reaction produces one product (re-
sorufin), whereas the AHH reaction results in mul-
tiple products (Burke and Mayer, 1974; Ronis and
Walker, 1985). There are also increased safety con-
cerns and increased expense for safe disposal of
reagents in AHH bioassays because assays for AHH
involve use of BaP, a known human carcinogen
(da Costa and Curtis, 1995; Williams et al., 1997).
The development of multiwell microtiter plate pro-
tocols for measuring EROD activity in cells has in-
creased both the speed and cost-effectiveness of the
H4IIE cell bioassay, especially when large numbers
of samples are to be analyzed (Kennedy and Jones,
1994; Tysklind et al., 1994). It is now common to
perform the entire H4IIE cell bioassay, including
cell plating, dosing, measurement of EROD activ-
ity, and cellular protein, in the same microtiter plate.
This method for multiwell plates is described later.
EROD activity describes the rate of the
CYP1A1-mediated deethylation of a phenoxazone
ether substrate, 7-ethoxyresorufin (7-ER), leading to
the formation of the product resorufin that has a free
hydroxyl group (reviewed in Whyte et al., 2000a;
Figure 1). The H4IIE EROD assay is a modifica-
tion of the method of Pohl and Fouts (1980). Cell
harvesting and preparation of a microsomal fraction
were originally performed similar to the AHH bioas-
say (Sawyer and Safe, 1982; Keys et al., 1986), but
now the reaction is generally carried out in the same
microtiter plate used for chemical dosing, based on
the work of Kennedy et al. (1993). After incuba-
tion, plates are washed 2–3 times with distilled water
(Tysklind et al., 1994) or with PBS (pH 7.4) if a live
cell assay is to be performed (see later discussion;
Whyte et al., 1998). Cells are lysed by either os-
motic shock from residual distilled water (∼20 µl)
or by quick freeze (−80◦C) and thaw cycle (Tysklind
et al., 1994). The main reagents added to the cell sus-
pensions include 7-ethoxyresorufin, dicumarol, and
NADPH (added last to initiate reaction; Table 4).
Reagents should be held at 37◦C in a water bath
before the EROD assay is performed. Dicumarol is
added as an inhibitor of oxidoreductase enzymes
(DT-diaphorase or NADPH oxoreductases) that can
catalyze the reduction of resorufin thereby reduc-
ing the estimation of EROD activity (Lubet et al.,
1985). Enzymatic activity can be estimated through
the use of batch assays, in which the amount of re-
sorufin produced is measured after a fixed period of
time (Clemons et al., 1996), or as kinetic assays, in
which resorufin production is repeatedly measured
at 60- to 90-s intervals (Tysklind et al., 1994). Ki-
netic assays yield more data per sample, assure the
linearity of the reaction rate, increase confidence in
the validity of the EROD estimates as compared to
batch assays, and are easily run using automated
TABLE 4
Example Reaction Components for Determination of 7-Ethoxyresorufin O-Deethylase
(EROD) in the H4IIE Cell Bioassay
Assay component Tillitt et al. (1991a) Tysklind et al. (1994) Whyte et al. (1998)
Plate size 15 × 100 mm
Petri dishes
96-Well
microtiter plate
48-Well
microtiter plate
Reaction vessel Cell suspension aliquots
in separate vessel
Reaction carried out
in dosing plate
Reaction carried out
in dosing plate
NADPH NADPH generator
systema
0.83 mM Not added
Dicumerol Not added 15 µM 160 µM
7-Ethoxyresorufin 0.6 µM 1.7 µM 4.87 µM
Final volume 1250 µL 120 µL 250 µL
Assay temperature 37◦C 37◦C 37◦C
Incubation time 10 min 15 min 15 min
Catalytic measurement Batch Kinetic (once/min) Batch
Protein assay Lowry et al. (1951) Bradford (1976) Lorenzen and Kennedy
(1993)
Approx. assay time 60 min/12 plates 40 min/96 wells 18 min/48 wells
a5 mM glucose 6-phosphate, 5 mM MgSO4, 3.5 mM NADP, 1.6 mg bovine serum albumin/ml in 0.1 M HEPES buffer,
pH 7.8 (Tillitt et al., 1991a).
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microtiter plate scanners. The fluorescence of re-
sorufin, the product of the CYP1A1-catalyzed re-
action, is measured with an excitation wavelength
of 550 nm and an emission wavelength of 585 nm
(Pohl and Fouts, 1980).
The EROD assay can also be performed on live
H4IIE cells (Clemons et al., 1996; Whyte et al.,
1998). This method was developed from previous
reports on the measurement of EROD activity in
intact human cells (Hammond and Strobel, 1992).
By allowing the intact cells to provide their own
NADPH as a reducing agent for the EROD reac-
tion, the need for externally provided NADPH is
significantly reduced or eliminated. The importance
of this is that NADPH is the most costly reagent in
the assay (∼$1.00 USD/mg or 5 cents/well in 96-
well plates). In cell suspensions it has been observed
that without the addition of NADPH, maximal
EROD activity is significantly reduced in the assay
(D. Nicks, Columbia Environmental Research Cen-
ter, Columbia, MO, personal communication). In
live H4IIE cells, Clemons et al. (1996) did not
report a reduction in maximal EROD activity in
the absence of NADPH compared to other reports,
but the maximal activity varied (TCDD maximum
ranged from 250 to 600 pmol/mg P/min). A TCDD
standard would have to be run with each microtiter
plate to control for this variation. The ability of
NADPH to penetrate cellular membranes in H4IIE
has not been examined. NADP+ does not read-
ily penetrate membranes in rat liver microsomes
(Takahashi and Hori, 1978), suggesting that
NADPH would not permeate into the lumen of the
endoplasmic reticulum, the location of CYP1A1, at
a fast rate. This may explain why Clemons et al.
(1996) did not observe an increase in EROD ac-
tivity with the addition of NADPH, but it does not
agree with the findings in H4IIE cell suspensions.
Experiments to determine the degree of NADPH
membrane penetration and intracellular concentra-
tion in H4IIE should be performed to help optimize
the use of this reagent in the bioassay. As of the
writing of this review, the majority of published pa-
pers use cell suspensions with NADPH added for
determination of EROD activity in H4IIE.
Both resorufin and protein standard curves
should be generated at the time the H4IIE cell
bioassay is run (Figure 4). Fluorescence inten-
sity of resorufin in chemically exposed cells can
be compared to a multipoint resorufin standard
curve with concentrations ranging from 0.06 to
40 pmol per well. Fluorescence intensity units
measured in each well can then be converted to
pmol of resorufin formed using a linear regres-
sion equation. The concentration of the resorufin
stock solution used to prepare the standards should
be routinely verified spectrophotometrically (ab-
sorbance = 571 nm). Commercial sources of the
resorufin stock solution include Molecular Probes
(Eugene, OR) and Fisher Scientific (Pittsburgh,
PA). Reported resorufin molar extinction coeffi-
cients used to calculate concentration vary among
laboratories. For example, van den Heuvel et al.
(1995b) reported a mean molar extinction coeffi-
cient of 54.0 ± 1.1 cm−1 mM−1, and Klotz et al.
(1984) reported 73 cm−1 mM−1. The extinction co-
efficient should therefore be reported along with
the resorufin standard curve (Goksøyr and Fo¨rlin,
1992).
The rate of resorufin production (pmol/min) is
standardized to cellular protein content. The protein
determination methods of Lowry (1951) or Bradford
(1976) are commonly used (Table 1). Many mi-
crotiter plate methods employ a fluorescence-
based protein assay measuring the reaction of flu-
orescamine with substances containing primary
amino groups (Udenfriend et al., 1972). This method
was adapted to microtiter plate assays by Lorenzen
and Kennedy (1993). The advantage of the mi-
crotiter plate fluorescamine assay over other pro-
tein measurement techniques used in the H4IIE cell
bioassay is that cellular protein is determined on the
same instrument and well as resorufin concentra-
tions are measured (Kennedy and Jones, 1994). Flu-
orescence intensity units (excitation 400 nm, emis-
sion 460 nm) are converted to milligrams protein
based on a seven point bovine serum albumin (BSA;
Fisher Scientific, Pittsburgh, PA; Sigma Chemical,
St. Louis, MO) standard curve with concentrations
ranging from 1.56 to 25 µg/well.
Cellular protein content can also be used to
normalize the chemical dose to which cells are ex-
posed (e.g., pg TCDD/mg protein) in addition to its
use in standardizing catalytic activity of the EROD
measurements (Tysklind et al., 1994). Normalizing
chemical dose is more pragmatic than simply ex-
pressing dose on a molar or mass-per-well basis,
but this protein standardization does not take into
account cellular growth that occurs over the expo-
sure period (e.g., 72 h). If by the end of the exposure
period the H4IIE cell growth is halted by contact in-
hibition (i.e., confluent), protein estimates will be
approximately the same among all wells, regardless
of differences in the initial plating density of cells.
Therefore it is important to ensure equal protein con-
tent among wells by verifying that the cell seeding
method used provides a uniform initial plating den-
sity of cells.
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FIGURE 4. General data flow during determination of EROD activity in H4IIE cells exposed to
environmental extract.
F. Data Analysis
Induction data from AHH or EROD assays
are plotted as dose-response curves. Dose-response
curves from environmental extracts or pure chem-
icals are compared to a TCDD standard curve to
develop relative potency factors (RPFs) or TCDD-
EQs∗ for those test samples (Figure 5). The H4IIE
cell bioassay has been used extensively to develop
RPFs for individual PHHs and PAHs (Safe, 1990;
Willett et al., 1997; Bols et al., 1997), but from
a biomonitoring standpoint, the determination of
TCDD-EQs in environmental samples is the great-
∗The standard notation of TEQs will be used when
we discuss toxic potency derived from chemical concen-
trations and TEF/RPF values. Throughout the text we will
use TCDD-EQs to designate toxic potency estimates de-
rived from the H4IIE bioassay.
est value of this assay. In keeping with the focus
of this review, TCDD-EQs will be discussed, but
this section applies equally to the determination
of RPFs. TCDD-EQs can be calculated in several
ways, including the ratio of the TCDD and test sam-
ple ED50s, the ratio of slopes of the linear portion
of these dose-response curves, or the ratio of other
multipoint estimates (Finney, 1964; Ankley et al.,
1991; Putzrath, 1995; Villeneuve et al., 2000a). The
assumption of all of techniques for TCDD-EQ de-
termination is that the test extract induces CYP1A1
through the same mechanism as the TCDD standard,
and therefore simply acts as a dilution of TCDD
(Finney, 1964; Villeneuve et al., 2000a). The method
of ED50 comparison is frequently used for H4IIE
cell bioassay data due to its simplicity (Jones et al.,
1993a; Koistinen et al., 1997; Huestis et al., 1997).
CYP1A1 activity is plotted versus the extract dose
(semilog plot) and an appropriate regression model
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FIGURE 5. Theoretical dose-response curves generated with the H4IIE cell bioassay.
is fitted to the data (for examples see Finney, 1964;
Kerr and Meador, 1996; Oris and Bailer, 1997).
The ED50s from the test extract are compared to
the ED50 of the TCDD standard to determine the
TCDD-EQ. In Figure 5A, it can be seen that the po-
tency of Extract 1 to induce CYP1A1 is 100-fold
less than that of TCDD. The calculations are per-
formed based on the description by Sawyer et al.
(1984):
Extract potency
= [TCDD ED50 (pg)/Extract ED50 (dilution)]
× [Extract volume (µl)/
TCDD dose volume (µl)]
= pg TCDD-EQ [1]
Relative potency
= pg TCDD-EQ/sample weight (wet weight, g)
= pg TCDD-EQ/g (wet weight) [2]
The coefficient of variation (CV) for the estimate of
TCDD-EQ is determined additively as described in
Tillitt et al. (1991a):
CVTCDD-EQ = [(CVE)2 + (CVS)2]1/2 [3]
where CVE and CVS are the coefficients of variation
for the extract ED50 and TCDD standard ED50,
respectively.
The ED50 comparison method is easy to per-
form, but is only valid when the dose-response
curves are fundamentally identical, differing only
in their position on the x axis (Figure 5A). This re-
quires that the dose-response curves for TCDD and
the test sample be parallel and attain identical maxi-
mal CYP1A1 activity (efficacy). The use of point es-
timates such as ED50s to determine TCDD-EQs has
been criticized in cases where one or both of these
conditions are not met (Putzrath, 1995; Villeneuve
et al., 2000a). When curves are parallel, point es-
timates taken from the same position at any point
along both the TCDD and sample curves will re-
sult in the same TCDD-EQ value. This is not the
case when curves are not parallel (Figure 5B). The
dose-response curve for Extract 4 is typical of par-
tial agonists, where the maximal response is not ob-
served even at apparently maximal receptor occu-
pancies. Relative to TCDD, the dose-response curve
of the partial agonist is shifted to the right. Depend-
ing on where the point estimate is taken from on
the curve (e.g., EC20, EC50, or EC80), the TCDD-
EQ of the sample will be different if the slopes of
the standard and the extract are not parallel. Tests
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of dose-response curve parallelism are rarely re-
ported in aquatic toxicology studies that use point
estimate comparisons (Oris and Bailer, 1997). Even
if statistical tests of parallelism are used, Villeneuve
et al. (2000a) state that these are not meaningful for
examining extract curves where no defined dose unit
can be used (i.e., extract doses can only be expressed
in terms of their dilution factor or gram equivalents;
see Section A). Partial agonists can further com-
plicate accurate TCDD-EQ determination because
they occupy a large number of receptors without
eliciting a response. This can competitively block
the effects of agonists with higher efficacies or full
agonists such as TCDD (see Section IIA, Accuracy,
for more information).
Another difficulty encountered with the ED50
ratio technique occurs when a dose-response curve
does not reach a maximal level of CYP1A1 activity
(Figure 5C, Extract 5). In this situation, it is im-
possible to calculate an ED50. In cases where no
maximum CYP1A1 activity is reached, a potential
solution may be to test the extract at greater con-
centration, but this is often not possible. The point
estimate comparison method, if used on curves with
unequal efficacy or no maximum, would result in
ambiguous TCDD-EQs, potentially invalidating the
conclusions of a study. To avoid the problems asso-
ciated with the point estimate method of TCDD-EQ
determination, techniques that compare a greater
range of data from the dose-response curves are
recommended (Putzrath, 1995; Villeneuve et al.,
2000a).
The most commonly reported multipoint com-
parison for calculating H4IIE bioassay-derived
TCDD-EQs is a modification of the slope-ratio
technique described by Finney (1964). This mod-
ified method was originally developed and used by
Tillitt et al. (1989) and is described in Ankley et al.
(1991) to estimate TCDD-EQs in Lake Michigan
Chinook salmon (Oncorhynchus tschawytscha) ex-
tracts. H4IIE cells exposed to flesh extracts from
these fish did not produce EROD dose-response
curves with maximal enzyme induction (i.e., re-
duced efficacy), preventing ED50 comparisons. To
determine a TCDD-EQ using the slope-ratio tech-
nique, the TCDD and extract doses are plotted on a
linear scale (Figure 5D). The rates of CYP1A1 ac-
tivity over the initial doses of TCDD or an extract
are proportional to the chemical doses. In this first-
order region, the rate of CYP1A1 activity increases
almost linearly (highlighted in Figure 5D). A greater
slope in this region of the curve indicates a higher
CYP1A1 inducing potency for a chemical. By com-
paring slopes of extract curves to the slope of the
TCDD standard, TCDD-EQs can be estimated, as
described by Tillitt et al. (1993):
Extract potency
= sample slope (EROD/µl of extract)/
TCDD slope (EROD/pg TCDD)
= pgTCDD-EQ/µl of extract [4]
Relative potency
= (pg TCDD-EQ/µl) × (extract volume, µl)/
sample wet weight (g)
= pg TCDD-EQ/g (wet weight) [5]
The advantages of this technique are twofold: First,
it allows the use of a greater range of data from the
dose-response curve in the TCDD-EQ calculation.
This provides more confidence in estimating the true
relative potency of an extract, rather than relying on
a single point from the dose-response curve. Second,
only the linear portion of the dose-response curve is
used in the calculation. Unlike the ED50 comparison
method, the slope-ratio technique allows TCDD-
EQs to be estimated from dose-response curves that
do not attain maximal TCDD induction. Thus, data
that would have been discarded can provide useful
information in a study (note that incidences of in-
complete dose-response curves should be reported
along with derived TCDD-EQs). These advantages
over the ED50 comparison method have increased
the popularity of the slope-ratio technique in studies
that use the H4IIE cell bioassay (Jones et al., 1993a;
Hoke et al., 1994; Ludwig et al., 1996).
An alternative technique that also employs a
range of dose-response data to estimate relative
potencies has been proposed by Villeneuve et al.
(2000a). Although the technique is described for
any type of relative potency estimate, this para-
graph will discuss its application to TCDD-EQs
specifically. To circumvent the problem of non-
parallel dose-response curves, TCDD-EQs are de-
termined from multiple points along the effective
range of CYP1A1 activity. A relative potency range
(RPF range) is determined rather than a single
TCDD-EQ estimate (e.g., 1 to 10 pg TCDD-EQ/g).
The breadth of RPF ranges indicate the degree of
certainty in the TCDD-EQ estimate. For instance, an
extract with a broad RPF range may be suitable for
general risk assessment applications, but not definite
enough for confident comparisons to other extracts
(Villeneuve et al., 2000a). To be most effective the
RPF range technique requires extract dose-response
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curves to have the same efficacy as the TCDD stan-
dard. RPF ranges are calculated by determining ef-
fective concentrations along the dose-response re-
gression line for multiple levels of CYP1A1 activity
(e.g., ED20, ED50, ED80) induced by an extract.
The corresponding values from the TCDD standard
curve are used to determine TCDD-EQs at each of
the selected points [Eqs. (1) and (2)]. When com-
paring RPF ranges among extracts, it is necessary to
use a standard range of response, arbitrarily defined
as, 20 to 80% (RPF20−80 range) of the maximum re-
sponse achieve for the TCDD standard (Villeneuve
et al., 2000a). The RPF range is defined as:
RPF20–80 range = minimum RPFi to maximum RPFi
[6]
If equal efficacy cannot be demonstrated, the
maximum RPF should be defined as the maxi-
mum CYP1A1 response for the sample in question
(Villeneuve et al., 2000a). In addition to the me-
chanics of the RPF-range technique, the authors in-
clude a dichotomous decision-making framework
to “guide derivation, critical evaluation, and use of
relative potency estimates based on in vitro bioas-
say results.” This framework consists of a series
of yes–no questions (e.g., was the observed sam-
ple efficacy markedly different from standard effi-
cacy?) that lead to a suggested method of TCDD-EQ
determination.
A hypothetical comparison of the three tech-
niques reviewed in this section of our review is
provided to allow evaluation of these methods
(Figure 6). The TCDD standard curve and the dose-
response curve for PHH A have the same slope and
equal efficacy. In this case, all three techniques are
valid and yield very similar RPFs. The curve for
PHH B also has equal efficacy, but the slope dif-
fers from that of the TCDD standard curve. Al-
though an ED50 can be determined, use of the ED50
FIGURE 6. Comparison of mathematical techniques used to generate TCDD-EQs from H4IIE cell
bioassay dose-response curves.
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comparison technique with this type of dose-
response curve is not recommended because as-
sumptions for the statistical analysis are violated.
The RPF20−80 range technique indicates that the
RPF for this curve varies depending on the position
examined on the curve, but this variation is not great.
The RPF determined using the modified slope-ratio
technique agrees with the RPF20−80 range. The dose-
response curve for PHH C did not attain a maxi-
mal level of CYP1A1 activity. Only the slope-ratio
technique allows an RPF to be determined for this
type of curve. Of the three techniques reviewed, the
slope-ratio technique allows the greatest flexibility
in determining TCDD-EQs from H4IIE cell bioas-
say data. This method makes use of the greatest
range of dose-response data and can be used to an-
alyze partial dose-response curves. Other methods
for estimation of relative potency exist, but these
have not yet been applied in the H4IIE cell bioassay
as of the writing of this review.
III. H4IIE CELL BIOASSAY
CHARACTERIZATION AND
METHOD VALIDATION
The use of H4IIE cells as a tool to identify the
presence of PHHs in environmental samples has un-
dergone many changes and modifications to opti-
mize the effectiveness of the bioassay. This section
will review specific analytical performance param-
eters of the H4IIE cell bioassay. Method validation
of the H4IIE cell bioassay is necessary to ensure that
the technique is accurate, specific, and reproducible
over the specified range that analytes will be tested.
A number of publications deal specifically with
characterizing the H4IIE cell bioassay (Bradlaw and
Casterline, 1979; Tillitt et al., 1991a; Sanderson
et al., 1996), and many others have reported perfor-
mance parameters in their results. The parameters
of focus in this section will be accuracy, precision,
specificity, limit of detection, limit of quantitation,
linearity, and range of the H4IIE cell bioassay. As
modifications and optimizations of the H4IIE cell
bioassay continue, it is important for researchers to
report the performance parameters of the method
being used to ensure the validity of their results,
to help others interpret the results, and to allow for
comparison among laboratories and/or studies.
A. Accuracy
Accuracy is the measure of exactness of an an-
alytical method, or the closeness of agreement be-
tween the value that is accepted as a “true” value
and the value found. For the H4IIE cell bioassay,
accuracy can be evaluated by comparing the cellular
response to extracts of known quantities of chem-
icals with the actual concentration of those chemi-
cals. In the initial characterization of the H4IIE cell
line bioassay performed by the U.S. Food and Drug
Administration, Bradlaw et al. (1979) reported good
correlation between the predictability of the cell cul-
ture system and the chemical identification of toxic
dioxin-like components extracted from gelatin sam-
ples. Gelatin extracts with high TCDD content pro-
duced high AHH activity and samples with negli-
gible amounts of TCDD gave no response in the
bioassay. In a more specific measure of accuracy,
Tillitt et al. (1991a) conducted spike/bioanalysis
studies to assess the ability of the H4IIE cell bioas-
say to accurately quantitate PHHs in biological sam-
ples. Experiments indicated that extracts of chicken
eggs spiked with TCDD and PCB 77 produced dose-
response curves of EROD activity that were in good
agreement with the dose-response curves seen when
the compounds were added directly to the cell cul-
tures. Slopes of the curves for the extracts and pure
compounds were not significantly different, indi-
cating no extraction or matrix effect on the response
of the bioassay. These experiments clearly demon-
strated that the H4IIE bioassay can accurately de-
termine the potency of PHH extracts.
The accuracy of the H4IIE cell bioassay may
be compromised at higher analyte concentrations
or in the presence of weak AhR agonists, although
this is not commonly observed in this cell cul-
ture system. Early experiments by Sawyer and Safe
(1982) indicated that concentration plots of several
PHHs versus their respective induced AHH activ-
ities gave dose-related increases in enzyme activ-
ity, which were usually followed by a decrease at
higher concentrations of the inducer (Figure 3A).
Similar observations have been attributed to cyto-
toxicity in H4IIE (Bannister et al., 1987), but de-
creases in enzyme activity in avian cell culture sys-
tems exposed to high PHH concentrations were
determined not to be due to loss of cell viability
(Lorenzen et al., 1997a). In avian and fish cell cul-
ture assays for EROD activity, it has been sug-
gested that this type of bell-shaped dose-response
curve may be the result of competitive inhibition
of CYP1A activity at high PHH concentrations
(Hahn et al., 1993; Kennedy et al., 1995). How-
ever, other yet unidentified mechanisms may also
play a role (Hahn et al., 1993). A relationship has
been suggested between PHH-induced accumula-
tion of highly carboxylated porphyrins and declines
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in EROD activity at high PHH concentrations, but
the mechanism involved remains to be determined
(Hahn and Chandran, 1996). Some studies have
demonstrated not only a decrease in catalytic activ-
ity but also a decrease in immunodetectable CYP1A
protein at high analyte concentrations (Gooch et al.,
1989; Lorenzen et al., 1997a). This supports the use
of CYP1A catalytic activity as an accurate estimate
of CYP1A protein induction.
A direct comparison of CYP1A1 protein lev-
els to CYP1A1 catalytic activity using the H4IIE
cell bioassay has not been done, but it has been
suggested that substrate inhibition of H4IIE EROD
or AHH activity may result in incorrect induction
estimates (Murk et al., 1996). To ensure the accu-
racy of TCDD-EQs determined with the H4IIE cell
bioassay, the extract dilution series should bracket
the full dose-response curve. If a decrease in activ-
ity is observed at high concentrations, this should
be reported with the presentation of TCDD-EQs.
In cases where inhibition is suspected (e.g., ex-
tracts from areas of high PCB contamination), it
may be useful to determine both catalytic activity
and immunodetectable protein levels of CYP1A1
on selected samples. If the dose-response curves of
CYP1A1 protein and catalytic activity differ signif-
icantly, other methods of TCDD-EQ determination
should be used. Sanderson et al. (1996) suggest the
use of a recombinant H4IIE cell line transfected with
a luciferase reporter gene under control of dioxin-
responsive elements (DREs) because luciferase ac-
tivity is insensitive to substrate inhibition in hep-
atoma cells (Sanderson et al., 1996; Richter et al.,
1997). It is important, however, that the stability of
the reporter gene is demonstrated over time before
this assay can be used routinely like the wild-type
H4IIE cell bioassay. It is likely that the H4IIE bioas-
say will continue to be used for biomonitoring due to
its availability and widespread knowledge base. The
phenomenon of substrate inhibition can be avoided
when using the H4IIE cell bioassay by using serial
dilutions of the dosing chemical or extract. There-
fore, the accuracy of TCDD-EQ determination us-
ing wild-type H4IIE cells should not be influenced
in most cases.
The accuracy of the H4IIE bioassay may also
be assessed through the use of a positive reference
material. In the same way as analytical chemists
maintain records of method performance, perfor-
mance materials may also be used for the H4IIE
bioassay. A positive reference material is a sample
of an appropriate matrix that has a known amount
of dioxin-like activity. The positive control material
can be tested with each batch or set of samples from
the field. The H4IIE bioassay results from testing
of the positive control material are maintained as an
ongoing control or reference in the form of a control
chart. Deviations of the H4IIE results of the positive
control material from the mean values of the control
chart can help alert analysts to potential problems
in a given batch of H4IIE bioassay results.
B. Precision
Precision is the measure of the degree of re-
peatability of an analytical method under normal
operation and is usually expressed as the percent
relative standard deviation or coefficient of varia-
tion (CV) for a statistically significant number of
samples. One test of the precision of the H4IIE
cell bioassay is to examine repeated TCDD stan-
dard curves. Tillitt et al. (1991a) reported the CVs
for within bioassay variance associated with TCDD
ED50s were small, with an average of 3.70%. Differ-
ent laboratories have reported among bioassay CVs
for TCDD ED50s based on long-term use of the
H4IIE cell bioassay. Overall estimates are generally
in the range of 25–35% (Table 5), indicating simi-
lar variability among labs. When the actual TCDD
ED50 values among labs are standardized to cell
number and compared, the values are remarkably
similar (Table 5, column 3), considering that several
different assay techniques were used and that the es-
timates cover a period of over, 20 years. Estimates of
ED50s for other PHH standards are also very similar
among different laboratories (Tillitt et al., 1991a).
This demonstrates a high level of reproducibility of
the H4IIE cell bioassay among different laboratories
over time.
Precision of the H4IIE cell bioassay is also quite
high for environmental extracts. Tillitt et al. (1991a)
reported that the CVs associated with extract ED50
estimates are generally in the range of 5–15%, and
that the final estimates of TCDD-EQs in these en-
vironmental samples had CV values between 10
and 20%. The authors noted that this precision is
only observed when a TCDD standard curve is run
with each set of environmental samples. This is be-
cause TCDD-EQ determinations are relative mea-
sures based on comparison to the cells response to
TCDD. There will always be subtle differences be-
tween each plate of cells and in day-to-day assay
conditions that will alter the induction of CYP1A1.
It is important to run a TCDD standard curve with
each set of environmental extracts to ensure match-
ing cell densities and assay conditions exist for both
TCDD standards and extracts.
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C. Limit of Detection and Limit
of Quantitation
The limit of detection (LOD) is defined as the
lowest concentration of an analyte in a sample that
can be determined to be statistically different from
a blank (Keith et al., 1983). It is expressed as a con-
centration in units of standard deviation and is gen-
erally based on the IUPAC definition of three stan-
dard deviations above the mean of the analytical
blank (Winefordner and Long, 1983). This value is
derived from statistical parameters easily obtained
from the TCDD standard curve. Using the IUPAC
model, there is a 0.13% chance that a signal (i.e.,
induced CYP1A1) measured at or above the detec-
tion limit would be due to random fluctuation of the
blank signal. The limit of detection for TCDD in the
H4IIE cell bioassay has been very consistently re-
ported at 0.031 pmol/plate (31 fmol; Table 5) when
the 100-mm petri dish format is used. This is an
indication of not only the high sensitivity of the as-
say to the presence of PHHs, but also supports the
excellent precision of the H4IIE cell bioassay over
time (described previously). Only rarely have H4IIE
detection limits for environmental extracts been re-
ported. Thomas and Anthony (1999) determined an
LOD of 0.043 pg TCDD-EQ/g egg wet weight for
great blue heron (Ardea herodias) egg extracts an-
alyzed with the bioassay. This is very close to the
LOD reported for TCDD (0.035 pg TCDD/g tissue)
in analysis of fish liver extracts using mass spec-
trometry (Parrott et al., 2000).
The limit of quantitation (LOQ) is defined as the
lowest concentration of an analyte in a sample that
can be determined with acceptable precision and ac-
curacy under the stated operational conditions of the
H4IIE cell bioassay. An LOQ value of 10 standard
deviations above the mean of the analytical blank
is recommended (Keith et al., 1983). Based on the
values reported in Table 5, the TCDD LOQ for the
H4IIE bioassay would be approximately 0.01 pmol
TCDD/plate. This should also correspond to the
LOQ for extract TCDD-EQs, but the value may be
affected by the presence of other chemicals in the
extract. In cases where a TCDD-EQ for an extract
is below the LOD or LOQ, a general practice is to
assign a value of one half of the LOD or LOQ for the
TCDD-EQ (Ankley et al., 1993; Giesy et al., 1997).
It is important to determine the potential in-
fluence that unknown components of the sample
matrix itself might have on CYP1A1 measurement
when determining the LOD or LOQ. Extracts of
environmental samples (i.e., sediment, tissue, etc.)
may contain small biologically active molecules that
are not removed during the cleanup procedure. It
would be difficult or impossible to reproduce the
sample matrix itself, but a field control sample from
a similar reference site can be used that is similar
to the test sample matrix (e.g., sediment upstream
of a PHH contaminated site). This “matrix control”
serves two purposes by indicating the potential in-
fluence of both small molecules from the extract and
the influence of the extraction procedure (e.g., resid-
ual extraction solvent in the carrier solvent) in the
absence of PHHs or related chemicals. The effect
on CYP1A1 induction by the matrix control should
also be compared to routine procedural controls and
solvent controls.
In the field of drug assay development, the LOD
and LOQ are described as the most important pa-
rameters for judging the quality and reliability of
data at the lower end of the concentration range of
interest (Kucharczyk, 1993). Yet very few H4IIE
cell bioassay studies report these parameters with a
description of how the values were derived. Values
for LOD and LOQ are particularly important when
examining extracts with very low CYP1A inducing
potency. Routine reporting of these parameters in
H4IIE studies would provide valuable information
to researchers deciding on whether the H4IIE cell
bioassay has the required sensitivity for their partic-
ular study.
D. CYP1A1 Activity Range
Range is the interval between the upper and
lower levels of CYP1A induction (inclusive) that
have been demonstrated to be determined with pre-
cision, accuracy and linearity using the method as
written. A number of variables may influence the
measured induction of CYP1A1, including plate
size, H4IIE cell density, volume of growth medium,
chemical carrier solvent, and assay endpoint (EROD
or AHH). The variability in activity is revealed by
comparing maximal CYP1A1 induction by TCDD
among different studies (Table 5). Many factors can
influence this maximal induction, and it is therefore
difficult to determine the exact reasons for differ-
ences among laboratories. Of greater importance for
accurate determination of TCDD-EQs is to ensure
that the range of TCDD-induced CYP1A1 activ-
ity among plates within the same study are not sta-
tistically different. Highly variable maxima among
TCDD standard curves in an assay would result in
different TCDD-EQs for a single extract depending
on which TCDD standard is used in the calculation
(or reduced accuracy if the mean of several TCDD
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standard curves is used). As described previously,
TCDD standard curves in the H4IIE cell bioassay
are highly repeatable in terms of linearity and range,
and generally do not pose a problem in the accurate
determination of TCDD-EQs.
E. Quality Assurance in the H4IIE
Cell Bioassay
The accuracy and consistency of the results
from the H4IIE cell bioassay can be ensured through
the use of defined quality assurance (QA) methods.
A good QA program will identify potential prob-
lems before they occur, prevent recurrence of iden-
tified problems, and provide confidence in the bioas-
say results. This is accomplished through the proper
replication of assayed samples (e.g., perform tripli-
cate analysis on at least 5% of samples), compari-
son of calibration against known standards, proper
maintenance of equipment, accurate sample track-
ing and chain-of-custody records, and documenta-
tion at all steps of sample processing. Suggested
elements of a good QA program for the H4IIE cell
bioassay are listed in Table 6. This section outlines
important H4IIE cell bioassay standard methods that
will make certain that the data generated have a high
probability of being of acceptable quality.
The QA measures for the H4IIE cell bioassay
can be divided into two categories: those measures
that assure the quality of the EROD assay data, and
those measures that assure the quality of the sam-
ple processing. The EROD assay QA measures in-
clude generation of TCDD, resorufin, and protein
TABLE 6
Suggested Elements of a Good Quality Assurance Program for the H4IIE Cell Bioassay
Component Quality assurance suggestions
H4IIE maintenance • Routinely check cells for mycoplasma or other contamination (see
Section IIB for cell culture procedures).
TCDD standards • Generate a composite TCDD dose-response curve from the average
of four independent determinations.
• TCDD composite curve should be generated for every 10 extract
samples tested.
Sample replication • Assay 5% of extract samples in triplicate.
Controls • Include positive control sample extract in triplicate with samples
for H4IIE analysis on each assay date (e.g., tissue extract from
organism containing known concentrations of PHHs demonstrated
to consistently induce CYP1A1 in H4IIE).
• Include appropriate matrix and solvent controls in triplicate for
H4IIE analysis on each assay date.
Reagents • Check concentrations of resorufin, ethoxyresorufin, and NADPH
reagents on each assay date using spectrophotometer.
• Concentrations are deemed acceptable if actual concentration is
within 10% of nominal concentration.
• Record source and lot numbers of all reagents used in laboratory
notebooks.
Resorufin and protein standards • Prepare eight-point resorufin and seven-point BSA (bovine serum
albumin) standard curves with six replicates for each concentration.
• Analyze resorufin and protein standard curves concurrently with
TCDD standards and sample extracts.
Equipment and instrumentation • Routinely inspect and perform preventative maintenance on all
instruments.
• Perform regular calibration of equipment.
Experimental information and data • Record data in bound notebooks with copies maintained in separate
secure area.
• Maintain hard copies of computer data files in project notebook.
• Verify all data reductions independently.
• Archive all computer data files as CD or tape backups.
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FIGURE 7. Control chart example for resorufin standard curve slope over multiple assays in the
H4IIE cell bioassay.
standard curves for each set of samples run on
a given day. The parameters from these standard
curves are compared with those generated on pre-
vious occasions in a control chart (Figure 7). By
examining the parameters from the standard curves
of each assay, the performance of the measurement
system can be demonstrated. The second category,
sample-processing QA measures, include running
the H4IIE cell bioassay with a positive control ma-
terial, a negative control material (i.e., matrix con-
trol), a reagent or procedural blank, and replicate
samples. As with the EROD assay QA measures,
control charts can be generated (Figure 8).
The control charts allow for statistical anal-
ysis of the parameters measured and establish-
ment of acceptance criteria for these parameters
(Taylor, 1981). To effectively use control charts,
a series of measurements are taken for the param-
eter in question (e.g., slope of the resorufin stan-
dard curve) and the standard deviation determined.
FIGURE 8. Control chart example for positive control material TCDD-EQ over multiple assays in
the H4IIE cell bioassay.
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TABLE 7
Acceptance Criteria for Quality Assurance Measures in the H4IIE Cell Bioassay
Acceptance criteria Acceptance criteria
Measure Parameter (within assay) (among assays)
TCDD standard curve Slope or ED50 r2 > 95%, p < .05;
CVwithin < 25%
Within 2σ of control chart mean
Resorufin standard curve Slope or ED50 r2 > 95%, p < .05;
CVwithin < 25%
Within 2σ of control chart mean
Protein standard curve Slope or ED50 r2 > 95%, p < .05;
CVwithin < 25%
Within 2σ of control chart mean
Replicate assays TCDD-EQ N/Aa CVamong < 50%
Positive control material TCDD-EQ CVwithin < 25% Within 2σ of control chart mean
Negative control material TCDD-EQ CVwithin < 25% Within 2σ of control chart mean
Reagent blank TCDD-EQ Mean ≤ LOQ Within 2σ of LOQ control chart
mean
Replicate samples TCDD-EQ CVwithin < 25% CVamong < 50%
aN/A, not applicable.
Acceptance criteria (i.e., control limits) are com-
puted from this standard deviation. For example,
values of the parameter that fall outside of the two
standard deviation limit (95% of the values) warn
of possible trouble, while values that fall outside of
the three standard deviation limit usually mean cor-
rective action is needed (Taylor, 1981). Acceptance
criteria for within-assay results should also be es-
tablished (e.g., the r2 of the TCDD standard curve
should have p < .05 and the CV for all TCDD stan-
dard curves run that day should be less than 25%).
Acceptance criteria for quality assurance measures
in the H4IIE cell bioassay are listed in Table 7.
F. Summary
The H4IIE cell bioassay is a reproducible and
sensitive bioanalytical tool. This section has re-
viewed reports of the analytical performance pa-
rameters of the H4IIE cell bioassay, highlighting its
high level of precision and accuracy, its known limits
of detection and quantitation, and the importance of
the range of CYP1A1 induction. It is equally impor-
tant for laboratories using the H4IIE cell bioassay to
have a sound quality assurance program to reduce
measurement errors and assure results of acceptable
quality. These practices are not specific to the H4IIE
cell bioassay and are reviewed by Keith et al. (1983).
Such a quality assurance program would include the
use of well-maintained and reliable equipment, cal-
ibration standards, and proper experimental tech-
nique. It is important to keep records of TCDD,
resorufin, and protein standard curves and monitor
these results for any changes over time. Participation
in interlaboratory comparisons (e.g., round-robin
studies) helps to ensure valid comparisons among
studies. Well-designed quality assurance programs
for use of the H4IIE cell bioassay help reduce both
inter- and intralaboratory variability.
IV. H4IIE CELL BIOASSAY AS A
SCREENING TOOL FOR
ENVIRONMENTAL CONTAMINANTS
The H4IIE cell bioassay has two basic purposes
in environmental testing: (1) the evaluation of the
relative potency of individual, chemicals; and (2)
the evaluation of the relative potency of chemical
mixtures taken from the environment. We will de-
scribe the utility of the H4IIE cell bioassay-derived
potency estimates when used in conjunction with en-
vironmental chemistry information in Section IV.A.
The subsequent section (IV.B) contains a review of
the studies in which the H4IIE bioassay has been
used to evaluate the overall potency of complex
mixtures of chemicals extracted from environmental
samples. Last, we discuss the interpretation of the
H4IIE cell bioassay results for hazard assessment
purposes.
A. TEQs Calculated from H4IIE
Relative Potency Factors (RPFs)
Regulation of groups of PHHs are often based
on single “representative” congeners (e.g., TCDD
for all PCDD/Fs) or based on the sum concentration
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of all members of a group (e.g., total PCBs; Clean
Water Act, U.S. EPA, 1977). These methods are seri-
ously flawed because they ignore the fact that differ-
ent PHHs in the same group can differ widely in their
toxic potency (Tillitt, 1999). Generation of H4IIE
TEQs is a fast and simple approach that avoids these
difficulties but is only now being considered for risk
assessment in the United States (Henningsen et al.,
1998). This section briefly reviews the use of RPFs
to calculate TEQs, as this topic has been dealt with
extensively elsewhere (Safe, 1987; van den Berg
et al., 1998; Birnbaum, 1999; Tillitt, 1999).
H4IIE RPFs (often labeled TEFs in early pub-
lications) are derived by comparing the activity of
AHH or EROD in cells exposed to individual PHHs
to the activity in TCDD-exposed cells:
Congener A RPF = ED50TCDD
ED50Congener A
[7]
RPFs derived using the H4IIE cell bioassay
serve two general purposes. First, these values can
be combined with analytical chemistry data to gen-
erate a TEQ, which can then be used for general
risk characterization or to validate the assumption of
an additive response in cells exposed to a complete
environmental extract (TCDD-EQ). Second, H4IIE
RPFs for a specific PHH can be combined with
mammalian RPFs determined from other in vitro
and in vivo response studies to arrive at a consensus
TEF value for that PHH (e.g., WHO-TEF values).
Determination and use of consensus TEFs are be-
yond the scope of this article, but the reader is di-
rected to a review by van den Berg et al. (1998) and
a series of reviews in Human and Ecological Risk
Assessment by Safe (1999), Birnbaum (1999), Tillitt
(1999), and Sanderson and van den Berg (1999).
The calculation of a TEQ requires measured
concentrations of selected PHHs in an environmen-
tal extract and their respective H4IIE RPFs (Table 8).
The specific congeners used in the calculation are
generally the PHHs determined to be the most potent
inducers of CYP1A1 activity in H4IIE. For exam-
ple, of the 209 PCB congeners, only a small number
induce CYP1A1 at detectable levels (Metcalfe and
Haffner, 1995), and therefore only concentrations
TABLE 8
Validating the Assumption of Additivity in the TCDD-EQ Model Using H4IIE Relative Potency
Factors (RPFs)
Concentration (pg/g) TEQ (pg/g)
Congenera H4IIE RPFb Extract 1 Extract 2 Extract 1 Extract 2
2,3,7,8-TCDD 1 25 30 25 30
1,2,3,7,8-PnCDD 1.13 6 8 6.78 9.04
1,2,3,4,7,8-HxCDD 0.49 0.5 0.5 0.245 0.245
1,2,3,6,7,8-HxCDD 0.23 4 5 0.92 1.15
1,2,3,4,6,7,8-HpCDD 0.09 0.5 1.5 0.045 0.135
2,3,7,8-TCDF 0.03 30 35 0.9 1.05
1,2,3,7,8-PnCDF 0.16 7 10 1.12 1.6
1,2,3,4,7,8-HxCDF 0.33 10 14 3.3 4.62
1,2,3,6,7,8-HxCDF 0.1 3 4 0.3 0.4
1,2,3,4,6,7,8-HpCDF 0.01 0.75 1 0.0075 0.01
3,3′,4,4′-TCB 0.00079 3000 3200 2.37 2.528
3,4,4′,5-TCB 0.0072 200 250 1.44 1.8
2,3,3′,4,4′-PnCB 0.000025 30,000 46,000 0.75 1.15
3,3′,4,4′,5-PnCB 0.1 700 750 70 75
3,3′,4,4′,5,5′-HxCB 0.0014 150 75 0.21 0.105

TEQ (pg/g) 110c 130c
TCDD-EQ (pg/g) 230c 1400c
TEQ ≈ TCDD-EQ ? Yes No
aPrefixes: T = tetra, Pn = penta, Hx = hexa, Hp = hepta. Suffixes: CDD = chlorinated dibenzo-p-dioxin, CDF =
chlorinated dibenzofuran, CB = chlorinated biphenyl.
bFrom Clemons et al. (1994, 1996).
cTo two significant digits.
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of these congeners are included in the TEQ cal-
culation. The PHH congeners that are strong in-
ducers of CYP1A1 (i.e., have high AhR binding
affinities) are approximate isostereomers of TCDD,
as determined from in vitro quantitative structure-
activity (QSAR) data, EROD and AHH measure-
ments in H4IIE, and toxicity (LD50) in mice and
rats (Bandiera et al., 1984; Safe et al., 1986, 1989;
Denomme et al., 1986; Kafafi et al., 1993). Predic-
tions of other CYP1A1 inducers based on structure
have been tested using the H4IIE cell bioassay (Liu
et al., 1993; Hewitt et al., 1998). It should be noted
that not all CYP1A1 inducers in H4IIE are struc-
turally similar to TCDD. For instance, several PAHs
(Willett et al., 1997) and sulfur-containing benzimi-
dazole compounds (Backlund et al., 1999) can cause
CYP1A1 expression in H4IIE.
Published H4IIE RPFs span two decades, be-
ginning with an initial set of PHH RPFs based on
AHH induction (Bradlaw et al., 1980). RPFs for
the major classes of CYP1A1 inducers (PHHs) are
compiled in Tables 9 and 10. The most complete
set of RPFs for PHHs are reported in a series of pa-
pers by Safe and coworkers (Sawyer and Safe, 1982;
Bandiera et al., 1984; Mason et al., 1986) based on
AHH induction. Published RPFs for an individual
congener can differ by several-fold depending on
the study examined (Tables 9 and 10).
To examine the variability in H4IIE RPFs and
its relation to assay technique, the CV was deter-
mined for individual chemicals where the RPF had
been determined more than three times (data not
shown). RPFs for individual chemicals were quite
variable among studies, with high CV values for
PCDDs, PCBs, and PCDFs. For PCBs and PCDDs,
this variability did not appear to be attributed to
specific techniques used to determine RPFs (e.g.,
removal of AHH derived RPFs or examination of
isooctane versus DMSO as carrier solvents did not
consistently reduce the CV). For PCDFs, AHH-
derived RPFs were generally higher than EROD-
derived RPFs, and their removal from the CV calcu-
lation did reduce the variability to some degree, but
not greatly. Despite this variability, an examination
of the rank order of RPFs among studies reveals very
similar patterns among labs. For instance, examina-
tion of a selected set of six PCDD RPFs from Table 9
determined by Bradlaw et al. (1979, 1980), Schrenk
et al. (1991), and Tillitt et al. (1991) revealed an al-
most identical rank order of potency for these com-
pounds. The rank order of PCB congeners in Table 9
is also generally similar among the different stud-
ies. Variation that is present is most certainly due
to differences in H4IIE culturing, assay conditions,
and possibly impurities in the chemical standards
discussed in Section II and not due to within assay
variation. Coefficients of variation for ED50s used
to calculate RPFs for individual congeners within
experiments are generally below 20% (Tillitt et al.,
1991a; Tysklind et al., 1994; Clemons et al., 1997).
It is therefore important in studies where TEQs are
to be compared to TCDD-EQs that the bioassay
conditions for TCDD-EQ determination closely re-
semble those used for the original generation of the
RPFs. This will ensure that the PHHs in an environ-
mental extract will elicit a biological response under
the same conditions used during exposure of H4IIE
cells to individual PHH congeners. In cases where
H4IIE RPFs are used only to generate TEQs from
analytical chemistry data, the selection of appro-
priate RPFs becomes more difficult. Improvements
over time in detection limits for H4IIE EROD in-
duction and the ability to obtain more reproducible
dose-response curves suggest greater confidence in
more recently published RPFs (Sanderson et al.,
1996). The sets of PHH RPFs determined in the,
1990s are less complete than those published in
the, 1980s, mainly because recent studies have fo-
cused on determining RPFs for only the most potent
CYP1A1-inducing congeners (i.e. congeners that
will contribute the greatest amount to the total TEQ;
Table 8). For this reason, the use of recently pub-
lished RPFs may provide more accurate TEQs, but
it appears that a research priority should be the gen-
eration of a complete set of RPFs for highly active
PHH and PAH congeners using the current H4IIE
cell bioassay protocol.
TEQs are determined by multiplying the con-
centration of each congener by its respective RPF
to give TEQ values specific to each PHH (Table 8).
The individual TEQ value for a PHH represents the
equivalent concentration of TCDD that would in-
duce the same CYP1A1 activity. Normalizing each
congener concentration to a TCDD concentration al-
lows the summation of the individual TEQs to gen-
erate a total TEQ in that extract (∑ TEQ). TEQs
can be used to rank environmental extracts by their
dioxin-like content. Comparing mean TEQs in envi-
ronmental samples collected from different regions
can help prioritize areas of concern (Tillitt et al.,
1991b; Rattner et al., 1994; Whyte et al., 1998;
van den Berg et al., 1998). The toxicological sig-
nificance of TEQs is discussed in Section IV.C.
H4IIE cells can also be dosed with the com-
plete environmental extract to generate a TCDD-
EQ (Section IIF). If the analytical measurement of
PHHs in an extract include all of the major CYP1A1-
inducing compounds present, and these compounds
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induce CYP1A1 additively, then the calculated TEQ
and the bioassay-derived TCDD-EQ should be rel-
atively equal (Table 8, Extract 1). The term “rela-
tively equal” is used to stress the fact that there is
inherent variability in a biological system such as
the H4IIE cell bioassay. Because of this variabil-
ity, even a two- to threefold difference in the TEQ
and TCDD-EQ for an environmental extract could
confirm an additive response to PHH exposure. Fac-
tors to consider when evaluating additivity include
the number of replicates for an extract, the indi-
vidual chemicals used in the TEQ calculation, and
differences between the methods used to derive the
H4IIE RPFs and the TCDD-EQ. With these consid-
erations in mind, if the TEQ and TCDD-EQ for an
extract differ by orders of magnitude, a number of
possible explanations exist (assuming no analytical
measurement error). A TCDD-EQ that is signifi-
cantly greater than its corresponding TEQ (Table 8,
Extract 2) may indicate that (1) other CYP1A1-
inducing compounds are present in the extract that
were not measured (Till et al., 1997), or (2) the PHHs
measured are not acting through an additive mech-
anism, but rather two or more PHHs present are
inducing CYP1A1 synergistically to give a greater
overall level of induction (Schmitz et al., 1996). A
TCDD-EQ that is orders of magnitude less than
its corresponding TEQ may indicate a less-than-
additive response in the H4IIE cells due to the chem-
ical mixture present. A less-than-additive response
has been demonstrated with binary combinations of
PCB congeners (e.g., PCB 153) and TCDD in the
H4IIE bioassay. Certain congener combinations can
result in less-than-additive EROD induction (Hahn
et al., 1993; Sanderson et al., 1996; Clemons et al.,
1998), but PCB/TCDD ratios need to be greater
than, 20,000:1. Despite potential chemical interac-
tions, additivity is generally observed in the H4IIE
cell bioassay (Schrenk et al., 1991; Willett et al.,
1997; Whyte et al., 1998). A number of field in-
vestigations that used the H4IIE cell bioassay are
summarized in Table 11, and in studies comparing
TEQs to TCDD-EQs, both additive and nonadditive
responses in the H4IIE cell bioassay are reported.
The next section will look in detail at the application
of the H4IIE cell bioassay to field investigations and
biomonitoring efforts.
B. H4IIE Toxic Equivalents
(TCDD-EQs) in Field Studies
and Biomonitoring
The H4IIE bioassay is a useful tool for evalu-
ating the amount of biologically active PHHs accu-
mulated in samples collected from the wild. TCDD-
EQs account for the varying biological potencies of
all of the different PHHs in an environmental extract.
In addition, several studies have reported correla-
tions between TCDD-EQs in wildlife extracts and
adverse effects in those populations (Section IV.C).
Therefore, TCDD-EQs indicate both exposure to
and potential toxicity of PHHs. However, the use of
TCDD-EQs to predict toxicity in non-mammalian
species should be approached with caution. Al-
though the presence of the AhR has been demon-
strated in a range of vertebrates, including fish, birds,
and amphibians (reviewed in Hahn, 1998), there is
some evidence that certain PHH congeners do not
induce the same AhR-mediated effects in all species.
For instance, differences in CYP1A inducing po-
tency for certain mono-ortho PCB congeners be-
tween fish and mammals have been demonstrated
(reviewed in van den Berg et al., 1998). This has led
to the suggestion that for hazard assessment pur-
poses, TCDD-EQs and RPFs should be generated
using species-specific cell lines for the organism in
question (Clemons et al., 1996, 1997; Kennedy et al.,
1996; van den Berg et al., 1998). A recent review
by Hahn (2002) includes a comparison of the rela-
tive sensitivities of in vitro bioassays for dioxin-like
compounds. The systems examined for CYP1A ac-
tivity included the H4IIE cell bioassay, a human
hepatoma cell line (HepG2), three hepatic fish cell
lines (PLHC-1, RTL-W1, and RTH-149), and chick
embryo hepatocytes. TCDD EC50 values for each
system were within the same order of magnitude
(0.01), excluding the HepG2 cell line, which was
approximately 10-fold higher than the other sys-
tems. This suggests that the different systems would
respond similarly to dioxin-like chemicals, but as
stated above, this is not the case for all PHH con-
geners. These theoretical considerations in mind,
relationships between TCDD-EQs and the injurious
effects of dioxin-like chemicals have been demon-
strated successfully in a number of non-mammalian
species (see Section C).
From a hazard screening perspective the
TCDD-EQ model offers a useful tool to estimate the
degree of PHH exposure and potential effects. There
are four major advantages that the H4IIE bioassay
has over analytical methods used to determine the
potency of PHHs in environmental samples. First,
because the H4IIE bioassay detects PHHs based on
a common mechanism of action for these chemicals,
the combined presence of all CYP1A1-inducing
compounds present in an extract is measured. The
H4IIE cell bioassay can assess these chemicals even
at concentrations below analytical detection limits
34
and it assesses chemicals that may not be on your
list of targeted analytes. Second, by examining all
CYP1A1-inducing chemicals in an extract simulta-
neously, the H4IIE bioassay integrates interactions
among the different PHHs present in the extract
(e.g., synergism or antagonism). Third, the H4IIE
cell bioassay is routinely more rapid than analytical
chemical measurements of the same set of analytes,
especially dioxins and furans. Fourth, the H4IIE cell
bioassay is considerably less expensive (10–25%)
than the cost of analysis of all the chemicals which
are measured by the bioassay. Because of these ad-
vantages, the H4IIE cell bioassay has been used ex-
tensively to assess the potency of PHH-containing
extracts from many trophic levels in the wild and
from abiotic matrices such as sediment and water.
For vertebrate species, a scan of Table 11 reveals
the derivation of H4IIE TCDD-EQs in 22 species of
fish, 14 species of birds, and 4 species of mammals.
These studies have been conducted in both aquatic
and terrestrial environments worldwide.
Field studies have used the H4IIE cell bioas-
say to make relative comparisons of TCDD-EQs
among environmental samples or among collection
sites (Table 11). Aquatic species, mainly fish, have
been examined in a variety of environments. Stud-
ies have used the H4IIE bioassay to identify areas
where fish have accumulated high concentrations
of TCDD-EQs relative to fish from reference lo-
cations. These regional comparisons have revealed
PHH contamination in fish from industrial regions
of the Great Lakes (Zacharewski et al., 1989; Giesy
et al., 1995; Tillitt et al., 1996) and in fish inhabit-
ing areas near pulp and paper mill effluents (van den
Heuvel et al., 1996; Whyte et al., 1998). In one of
the few studies that report TCDD-EQs in aquatic in-
vertebrates, McDonald et al. (1994) and Kennicutt
et al. (1995) reported 10-fold greater TCDD-EQs
in clams from the heavily PCB-contaminated Win-
ter Quarters Bay, Antarctica, as compared to clams
collected from a uncontaminated reference location
(Table 11). Winter Quarters Bay, directly adjacent
to the McMurdo Research Station, is known to have
extensive areas of submerged abandoned equipment
and waste (Kennicutt et al., 1995). Concentrations
of TCDD-EQs in the clam tissues were correlated
with tissue PCB concentrations and confirmed the
accumulation of toxic chemicals in the biota of
McMurdo Sound.
The H4IIE cell bioassay has been used exten-
sively to determine differences in PHH contamina-
tion among avian populations (Table 11). A series
of investigations in the Great Lakes has revealed
high concentrations of TCDD-EQs in populations
of birds inhabiting the Fox River and Green Bay,
WI (Tillitt et al., 1989, 1991b, 1992, 1993; Jones
et al., 1993b, 1994; Ludwig et al., 1996). Where
concentrations of TCDD-EQs in birds from both
reference and contaminated sites are reported, rel-
ative levels of PHHs can be approximated based
on mean concentrations. Comparisons of “baseline-
normalized” TCDD-EQs rather than absolute values
reduces the influence of different H4IIE bioassay
techniques (e.g., EROD vs. AHH-derived TCDD-
EQs; Zacharewski et al., 1989). Double-crested cor-
morant (Phalacrocorax auritus) eggs and chicks
collected at Little Gull Island, Green Bay, had mean
TCDD-EQs roughly three- and ninefold higher, re-
spectively, than eggs and chicks of the same size
from the Apostle Islands, Lake Superior (Jones
et al., 1994). Similarly, mean TCDD-EQ in Forster’s
tern (Sterna forsteri) eggs from Green Bay were ap-
proximately ninefold higher than eggs from a ref-
erence lake in Wisconsin (Tillitt et al., 1993). A
six-fold increase in black-crowned night heron
(Nycticorax nycticorax) embryo TCDD-EQ mean
was recorded in birds from Green Bay compared to a
reference lake in Virginia (Rattner et al., 1994). The
significance of the identical relative levels of TCDD-
EQs in both cormorant and tern eggs is difficult to
interpret, but may be related to similar maternal di-
ets of birds in these locations. In all three species of
birds, TCDD-EQs concurred with residue analysis
in the same tissues reported as TEQs or ∑PCBs
(Table 11). Biological effects of these concen-
trations of TCDD-EQs and PHHs in fish-eating
waterbirds is discussed in Section C. The H4IIE
cell bioassay has also been used to estimate
PHH contamination of bird populations in Europe
such as white-tailed sea eagles, Halieetus albicilla
(Koistinen et al., 1997) and osprey, Pandion haliae-
tus (Hanberg et al., 1991).
Field studies can use the H4IIE cell bioas-
say exclusively as a screening tool to locate
populations of PHH-contaminated organisms, but
often, analytical chemistry data are presented along-
side TCDD-EQs. This additional information can
be used to determine the classes of chemicals
that are the major contributors to elevated TCDD-
EQs, thereby supporting hypotheses of contaminant
sources or suggesting new ones. Concentrations of
TCDD-EQs are often related to direct concentra-
tions of PHHs or to the overall relative potency of
measured PHHs determined as TEQs (Table 11).
When H4IIE-derived RPFs and analytical chem-
istry data are available, TCDD-EQs should be com-
pared to TEQs developed from those H4IIE-derived
RPFs.
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Significant correlations exist between analyti-
cal measurements of PHHs/PAHs and TCDD-EQs
in eleven out of twelve studies reviewed (Table 11).
Concentrations of PCBs were considered a priori to
be the dominant contributor to TCDD-EQs in sev-
eral studies in Lake Michigan, and indeed strong
correlations existed between total PCB concentra-
tions and TCDD-EQs in fish and birds from this
region (Ankley et al., 1991; Jones et al., 1993a,
1993b; Williams et al., 1995). This is supported
by earlier work, where it was determined that pla-
nar PCBs accounted for over 90% of the TEQs in
Forster’s tern (Sterna forsteri) eggs from Green Bay,
Lake Michigan (Kubiak et al., 1989). Other major
contributors to TCDD-EQs in extracts from Great
Lakes wildlife are PCDDs and PCDFs. Zacharewski
et al. (1989) reported significant correlations be-
tween TCDD-EQs in Great Lakes fish compos-
ites and concentrations of
∑
PCDDs and
∑
PCDFs.
These TCDD-EQs were greater than their cor-
responding TEQs, suggesting that other inducing
chemicals (such as non-ortho PCBs) were present
in the extract. In a series of field investigations and
caging experiments in the vicinity of bleached kraft
pulp mills around Lake Superior, comparisons of
TCDD-EQs, TEQs, and analytical measurements of
PCDDs and PCDFs in white sucker and lake trout
(Salvelinus namaycush) extracts suggested the pres-
ence of CYP1A1 inducing compounds other than
just PCDD/Fs (van den Heuvel et al., 1994, 1995a,
1996; Whyte et al., 1998; Parrott et al., 2000). By
combining the in vitro results of the H4IIE bioas-
say with in vivo measures of CYP1A1 activity, the
authors were able to surmise that the unidentified
compounds were potent CYP1A1 inducers, rela-
tively water soluble, and rapidly metabolized and
excreted (van den Heuvel et al., 1995a; Whyte et al.,
1998). In areas of complex contamination such as
these, the use of both analytical and biological mea-
sures of suspected EROD inducing compounds can
play a critical role in pinpointing the source of con-
tamination in an environment. If resources permit,
PCDDs, PCDFs, and planar PCBs with the high-
est TEFs should all be measured in environmental
extracts. This would allow a more precise deter-
mination of contributing congeners to the overall
TEQs/TCDD-EQ.
Caution should be exercised when making con-
clusions based on correlations between contaminant
concentrations and TCDD-EQs. Smith et al. (1994)
noted that TCDD-EQs in Chinook salmon (On-
corhynchus tschawytscha) eggs were strongly cor-
related not only with
∑
PCB (r2 = .71, p < .05),
but also with
∑
DDT (r2 = .65, p < .05) and mirex
(r2 = .65, p < .05). These two insecticides are not
reported to bind to the AhR to induce CYP1A1
(Vodicnik et al., 1981; Delescluse et al., 1998), and
therefore they would not contribute to the TCDD-
EQ. In fact, p,p′-DDE had no effect on CYP1A1
induction in H4IIE cells over a wide range of con-
centrations (Tillitt, 1989; Tillitt et al., 1991a). It is
likely that heavily polluted regions will have a num-
ber of contaminants with elevated concentrations,
although only a portion of them would be inducers
of CYP1A1. It should be noted here that a correla-
tive relationship between two variables, particularly
in an environmental study, does not define a causal
relationship between the variables. Causality in en-
vironmental toxicology is determined by a set of cri-
teria (Fox, 1991) that includes correlation between
the causative agent and an effect, but is certainly
not defined by it. Comparing TCDD-EQs to TEQs
to estimate the major EROD-inducing chemicals in
an extract is more straightforward.
Relationships between TCDD-EQ and TEQ
values that support the additive model of CYP1A1
induction in H4IIE have been observed in sev-
eral studies. Some of these studies include PAH-
contaminated American oysters, Crassostrea vir-
ginica (Willett et al., 1997), PHH-contaminated
Atlantic herring, Clupea harengus (Hanberg et al.,
1991), common carp, Cyprinus carpio (Giesy et al.,
1997), and BKME-exposed lake trout, Salvelinus
namaycush (Whyte et al., 1998). In other cases,
however, bioassay-derived TCDD-EQs and TEQs
are significantly correlated, but the ratio of the cor-
responding values is not equal to one. These differ-
ences may be due to additive or less-than-additive
interactions among PHHs, as described in Section
IV.A. In general, TEQs and TCDD-EQs have been
significantly correlated, as can be seen in 15 of 16
(94%) of field studies where both measurements
were reported (Table 11).
In cases where a one-to-one correspondence
was not observed, the ratio of TCDD-EQs to TEQs
was generally greater than 1, suggesting the pres-
ence of unaccounted-for EROD inducers in extracts
presented to H4IIE. It is important to remember,
however, that deviations from additivity may not
be due to chemical interactions, but due to limita-
tions of the bioassay itself. It is estimated that the
resolution of the H4IIE cell bioassay is not suf-
ficient to conclude that TCDD-EQ-to-TEQ ratios
with values between 0.5 and 2.0 are different from
one (Giesy et al., 1997). Furthermore, H4IIE RPFs
can best be described as “order-of-magnitude” es-
timates, and therefore we would not expect TEQs
and TCDD-EQs to follow an exact 1:1 relationship
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in the majority of cases. These are important consid-
erations when making statements about deviations
from strict additivity. Even when complex models
are employed, the relationship between TCDD-EQs
and TEQs is difficult to interpret. Giesy et al. (1997)
employed a mass-balance approach to determine
if all of the CYP1A1 inducing chemicals in com-
plex mixtures of fish extracts were accounted for.
This technique involved correcting TCDD-EQ con-
centrations for estimated recovery, considering po-
tential nonadditive interactions based on estimates
of PCB antagonism, and approximations of contri-
bution to TCDD-EQ from polychlorinated naph-
thalenes (PCNs), polychlorinated diphenyl ethers
(PCDEs), and polychlorinated dibenzothiophenes
(PCDTs). Although the authors were able to con-
clude that PCNs, PCDTs, and PCDEs were not re-
sponsible for a TCDD-EQ-to-TEQ ratio greater than
1, the identity of CYP1A1-inducing chemical in the
extract remained undetermined. This information is
only presented to reveal the complexity of nonad-
ditive results; in general additivity is supported in
the majority of studies that employ the H4IIE cell
bioassay (see Section IV.A).
Temporal comparisons of TCDD-EQs in
wildlife or abiotic samples can also be carried out.
Changes in extract TCDD-EQs over time can be
used to monitor the success of remediation efforts
or to track PHH body burdens at different life
stages in a species. The H4IIE bioassay was used
to measure TCDD-EQs in liver extracts from white
sucker exposed to pulp mill effluents over a four-
year period (van den Heuvel et al., 1996). Follow-
ing the introduction of effluent secondary treatment
and a transition from chlorine to chlorine dioxide
bleaching at the mill, concentrations of TCDD-EQs
and PCDD/Fs declined. As mentioned previously,
in vivo measures of hepatic EROD in white suck-
ers in this study did not decrease, suggesting that
PCDD/Fs are not the dominant CYP1A1 induc-
ing compounds in BKME (van den Heuvel et al.,
1996). The effects of bioconcentration and bioaccu-
mulation of PHHs can be observed by monitoring
TCDD-EQs in tissues of organisms at different ages.
In general, concentrations of TCDD-EQs in organ-
isms from a concentrated area increase with body
mass, reflecting the accumulation of PHHs over an
organisms life (Ankley et al., 1993; Jones et al.,
1993a). An exception to this accumulation pattern
is seen in fast-growing chicks of fish-eating water-
birds. Studies have reported that concentrations of
PHHs and/or TCDD-EQs are greater in the eggs
of terns (Sterna forsteri, Sterna paradisaea, Sterna
hirundo) and black-crowned night herons (Nyctico-
rax nycticorax) than in newly hatched chicks, in-
dicating a drop in PHH concentration after hatch
(Scharenberg, 1991; Ankley et al., 1993; Rattner
et al., 1996). It is suggested this effect is due to
growth dilution of PHHs as the chick body mass
increases (Scharenberg, 1991; Jones et al., 1994).
Growth is so rapid during the early life stages that
although the absolute mass of PHHs increases over
time, this accumulation is not detectable on a con-
centration basis alone. For this reason it is impor-
tant to report TCDD-EQs in juvenile organisms as
both concentration and absolute mass. For exam-
ple, a regression analysis of TCDD-EQ mass versus
age in Forster’s tern nestlings from the Fox River
estimated a TCDD-EQ uptake rate of 270 pg/d (Ta-
ble 11; Ankley et al., 1993).
Concentrations of TCDD-EQs at differ-
ent trophic levels can indicate the transfer of
biologically-active PHHs through the food chain.
Jones et al. (1993a) investigated biomagnification of
TCDD-EQs in the Great Lakes ecosystem. TCDD-
EQs increased with trophic status through sediment,
forage fish, piscivorous fish, and piscivorous birds.
This suggests that the major route for TCDD-EQ
accumulation in this ecosystem is the food chain
(Jones et al., 1993a). The observed bioaccumulation
of TCDD-EQ is consistent with what is known about
transfer of PHHs to the top of an aquatic food chain
(Fisher, 1995). Species with similar food habits had
similar levels of TCDD-EQs. Other studies have
also suggested the potential for the biological po-
tency of PHHs to increase with each trophic trans-
fer (Hanberg et al., 1991; Koistinen et al., 1997).
The biological hazard associated with this increase
is uncertain (Section C).
Most TCDD-EQ determinations are conducted
with biological matrices, but extracts of water and
sediment can also be tested with H4IIE cell bioas-
say (Table 11). The biological significance of the
TCDD-EQ in abiotic matrices, such as soil, sedi-
ment, water, or air, is impossible to evaluate. This
is because the complex processes of environmental
transport are chemical specific. Thus, the concen-
trations of TCDD-EQs developed for abiotic matri-
ces are of limited value and may only be compared
within a matrix and contaminant source area, on a
relative basis. This is the same caution which exists
for TEQs developed for abiotic matrices (van den
Berg et al., 1998). Concentrations of TCDD-EQs
in sediment are generally greater compared to bi-
ological extracts because of the greater number of
AhR ligands in sediments. Sediments contain chem-
icals which are not found in biota. For example,
PAHs are readily found in sediments, especially in
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urban or industrial areas, while PAHs are only found
in small concentrations in fish due to metabolism.
There are other compounds that may be found in
sediment but are not transferred to the biotic compo-
nents of the aquatic food chain. The lack of transfer
of chemicals can occur for a variety of reasons, but
the net result is lower numbers of compounds and
lower concentrations of many compounds in biota
(such as fish) compared to underlying sediments.
Additionally, the high organic content of sediment
and the fact that TCDD-EQs are typically expressed
relative to dry weight of sediment tend to elevate
TCDD-EQs in sediment (Hoke et al., 1994; Gale
et al., 2000).
Concentrations of TCDD-EQ in water samples
are difficult to detect without concentrating samples.
Several studies have used lipid-containing semiper-
meable membrane devices (SPMDs) to sequester
PHHs and PAHs from surrounding water and then
expose H4IIE cells to dialyzed extracts of the lipid
(Lebo et al., 1995; Parrott and Tillitt, 1997). TCDD-
EQs in abiotic matrices from different locations can
serve as a valuable screening tool for the presence of
CYP1A1-inducing compounds and direct research
efforts to the most heavily contaminated regions.
The biological significance of these measurements
is unclear, as stated earlier, and should only serve
for relative comparisons.
C. H4IIE-Derived TCDD-EQs as a
Tool for Hazard Assessment
Results of the H4IIE cell bioassay can be
categorized based on concerns due to dioxin-like
effects. The bioassay integrates the total of the
dioxin-like chemicals present in environmental ex-
tracts. The amounts of chemicals present in en-
vironmental samples are not delineated with this
assay. Chemical-specific risk assessments require
traditional analytical chemistry data on individ-
ual chemicals. However, data from the H4IIE cell
bioassay can be used to conduct hazard ranking
of sites in a study or monitoring program. TCDD-
EQs are mechanistically well suited to predictions of
toxic effects in organisms. The relationship between
H4IIE-derived TCDD-EQs, PHHs, and detrimental
effects was first explored by Safe and coworkers
by demonstrating correlations between the in vitro
response of H4IIE and the in vivo toxicity in rats
after administration of selected PHHs (reviewed in
Safe, 1990). Since that time, several authors have
used the H4IIE cell bioassay in field situations to
determine the relationship between TCDD-EQ es-
timates in organisms and the hazard to their health
and reproductive well-being.
The strongest evidence linking adverse symp-
toms of PHH exposure to TCDD-EQs comes from
studies of colonial fish-eating waterbirds nesting in
polluted environments. In the Great Lakes, popula-
tions of gulls (Larus argentatus, Larus delawaren-
sis), double-crested cormorants, and Caspian terns
have exhibited unusually high embryo mortality
rates, deformities at birth, and altered reproductive
behavior (Tillitt et al., 1989, 1993; Ludwig et al.,
1995). Greater than average concentrations of PHHs
in the tissues of these birds are believed to be a
major contributing factor in these effects (Kubiak
et al., 1989; Brunstro¨m, 1990). Results from the
H4IIE bioassay have strongly implicated PHHs in
extracts from eggs and tissues of these birds to in-
creased incidence of toxic effects. Tillitt et al. (1989)
determined TCDD-EQs in eggs of double-crested
cormorants from 41 colonies throughout the Great
Lakes. When colonies were ranked according to
their TCDD-EQs, the greatest values were found
in egg composites from areas with high PHH con-
centrations and the most severe reproductive effects.
Although not a direct cause-and-effect relationship,
the results of this study suggest at least a partial
role of PHHs in the reproductive impairments of
double-crested cormorants in the Great Lakes (Tillitt
et al., 1989). These results have been supported
by subsequent studies that strongly relate elevated
TCDD-EQs to deformities, biochemical changes
(decreased retinol, increased porphyrins), reproduc-
tive failure, and death in different species of birds
from this region (Table 11 summaries: Tillitt et al.,
1991b, 1992, 1993; Ludwig et al., 1996). Extracts
of double-crested cormorants from Green Bay, Lake
Michigan, have also been tested for their toxicity
to developing embryos (Powell et al., 1997). These
in vivo studies confirmed the toxicity of the PHH
mixtures as predicted by the H4IIE bioassay. To-
gether these studies conclude a causal relationship
did exist among PHH contaminants and adverse re-
productive effects in colonial waterbirds in Green
Bay and the Great Lakes.
TCDD-EQs have been found to be a better pre-
dictor of detrimental effects than certain direct mea-
surements of PHHs (Tillitt et al., 1992; e.g. PCBs;
Ludwig et al., 1996). This is expected, because
TCDD-EQs can integrate the potential for AhR-
mediated effects of all PHHs in an extract and the
interactions among them. Tillitt et al. (1992) found
the potency of PCB-containing extracts of double-
crested cormorant eggs correlated with cormorant
reproductive success at those same colonies in the
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Great Lakes. These studies demonstrate the broad
utility of H4IIE cell bioassay in environmental haz-
ard assessment and screening.
The H4IIE bioassay has been applied less ex-
tensively in hazard assessment for fish populations.
Contaminants such as PHHs are believed to be
partly responsible for adverse reproductive impacts
on salmonid populations in the Great Lakes and
the Baltic Sea (Paasivirta et al., 1995; Fitzsimons,
1995; Palace et al., 1998). Ankley et al. (1991) used
the H4IIE cell bioassay to determine TCDD-EQs in
PCB-containing extracts of female Chinook salmon
(Oncorhynchus tschawytscha) flesh and egg sam-
ples from Lake Michigan (Table 11). The concen-
tration of TCDD-EQs in eggs was five times higher
than in maternal flesh samples, while total PCBs
were only 2.5 times greater. This suggested that ma-
ternally transferred PCBs had an enhanced potency
relative to the PCBs in the muscle tissue, possibly
due to greater transfer of more toxic planar PCBs
to the eggs (Ankley et al., 1991). Only PCB con-
centrations in eggs were found to be significantly
correlated with hatching success, but there did ap-
pear to be a TCDD-EQ threshold of 100 pg/g, above
which hatching success was significantly reduced.
The TCDD LD50 values for lake trout eggs from a
variety of exposure methods are as follows: injec-
tion studies, 50 pg/g; waterborne exposure, 47 pg/g;
and maternal transfer, 59 pg/g (Walker et al., 1996).
These values are quite comparable to the threshold
suggested by Ankley et al. (1991).
Smith et al. (1994) determined H4IIE-derived
TCDD-EQs in coho salmon (Oncorhynchus kisutch)
and Chinook salmon eggs collected from the Great
Lakes. Eggs were reared under laboratory condi-
tions, and TCDD-EQ estimates were compared to
embryonic mortality and organochlorine contami-
nant concentrations in these fish. Mortality that was
observed between hatch and swim-up stages did not
correlate with TCDD-EQ, total PCB, or organochlo-
rine insecticide concentrations. This corroborated
the findings of Ankley et al. (1991), suggesting that
PHHs are not the singular factor causing the lack of
reproductive success in Great Lakes salmonid popu-
lations in the 1990s. Current studies are examining
the potential for PHHs to act in concert with de-
creased levels of vitamin B1 (thiamin) observed in
Great Lakes and Baltic Sea salmonid eggs to in-
fluence the reproductive success of these species
(McDonald et al., 1998).
Mammalian populations have been examined
less extensively than birds and fish, but one study
in particular has provided some of the most impor-
tant evidence for the effects of PHHs in top preda-
tors. Mink (Mustela vison) are highly sensitive to
the effects of PHHs (Aulerich et al., 1973, 1985;
Tillitt et al., 1996). This was clearly demonstrated
when farm-raised mink were fed diets containing in-
creasing proportions of Saginaw Bay carp (Cypri-
nus carpio). The TCDD-EQs in control diets and
diets containing 10%, 20%, and 40% carp were 1.0,
19.4, 40.0, and 80.8 pg/g, respectively (Tillitt et al.,
1996). Reproductive toxicity was observed in all
of the carp treatment groups (Heaton et al., 1995).
Reduced body weights of kits born to females oc-
curred in the 10% and greater carp diet treatments,
and the 40% carp diet resulted in a significant de-
crease in the number of live kits born to females.
The mink reproductive no-observed-adverse-effect
level (NOAEL), determined in the 10% carp diet
treatment group, was 19.4 pg/g TCDD-EQ (Tillitt
et al., 1996). From the results of this study, it is
clear that mink are more sensitive to PHH-induced
reproductive toxicity than most other species that
have been tested (Peterson et al., 1993).
The H4IIE cell bioassay has also been used
to develop “hazard quotients” (Giesy et al., 1995;
Koistinen et al., 1997). The relative hazard of
TCDD-EQs in organisms can be calculated by di-
viding the concentration of these TCDD-EQs by
an estimated no-observable-adverse-effect concen-
tration (NOAEC; Koistinen et al., 1997). A value
of 1 would indicate that a population is just at the
threshold for adverse effects and values greater than
1 would indicate a probability that adverse effects
could occur. Giesy et al. (1995) measured TCDD-
EQs, organochlorine insecticides, PCBs, and mer-
cury in composite samples from eight different fish
species that serve as prey for bald eagles (Haliaee-
tus leucocephalus). These fish were collected above
and below hydroelectric dams on three Michigan
rivers, with fish residing below the dams having ac-
cess to the Great Lakes. By combining the hazard
quotient technique with biomagnifications factors
for accumulation of TCDD-EQ from fish to eggs
of bald eagles, it was determined that the TCDD-
EQs in fish below the dams presented a significant
hazard to bald eagles (i.e., hazard quotients were all
greater than 1). This technique has also been used by
Koistinen et al. (1997) to conclude that TCDD-EQs
in white-tailed sea eagle eggs are likely causing ad-
verse effects in the Baltic populations of these birds.
The hazard quotient technique can be applied to any
species for which a TCDD (or TCDD-EQ) NOAEC
has been determined. NOAECs from closely related
surrogate species may also be used (Giesy et al.,
1995). A note of caution for this approach is re-
quired. The assumption that must be made with this
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use of TCDD-EQs can be great. The trophic transfer
of dioxin-like chemicals is chemical specific, so the
use of TCDD as the model compound for trophic
transfer coefficients may lead to inaccuracies in the
resultant hazard quotients. Thus, caution must be
taken in the interpretation of these exercises.
The results of the H4IIE cell bioassay represent
all of the PHHs present in an extract. These chemi-
cals have a range of bioaccumulation or biomagni-
fication potentials and for this reason, a chemical-
specific risk assessment is not possible. However,
if the potencies of TCDD-EQs as measured by the
H4IIE cell bioassay were evaluated as if they were
derived from TCDD alone, then relative hazard cat-
egories may be developed. These hazard categories
can be based upon the toxicity of dioxin-like con-
taminants to a species most sensitive life stage, the
developing embryo or fetus, and the expected poten-
tial for biomagnification. Toxicity reference values
(TRVs) of TCDD in fish and wildlife range from
35 pg TCDD/g egg in fish based on lake trout early
life stage (ELS) mortality (Walker et al., 1994), to
100 pg TCDD/g egg for avian embryo lethality taken
from a feeding study with ring-necked pheasants
(Nosek et al., 1993). Reproductive toxicity in mink
occurs at 60 pg TCDD/g liver in the adult mink
(Tillitt et al., 1996). Taken together with the degree
of biomagnification expected for TCDD, a hazard
category may be developed. The use of TCDD bio-
magnification values simply provides a reference
point from which to make relative screening cate-
gories. The biomagnification factor of TCDD from
forage fish into predatory fish is approximately 1.0
(Jones et al., 2001). The biomagnification factor of
TCDD from fish into the eggs of fish-eating birds is
approximately 20 (Braune and Norstrom, 1989), and
the biomagnification factor of TCDD from fish into
mink livers is approximately 11 (Tillitt et al., 1996).
Hazard categories may be developed from simple
division of the toxicity reference values by the bio-
magnification factors (TRV/BMF). Fish health may
be expected to be impaired when TCDD-EQs in
fish are 35 pg/g (TRV/BMF = 35/1). Avian re-
productive health may be expected to be impaired
when TCDD-EQs in fish are 5 pg/g (TRV/BMF =
100/20), while mammalian wildlife reproductive
health can be expected to be impaired when TCDD-
EQs in fish are 5 pg/g (TRV/BMF = 60/11). The
TRV estimated by Tillitt et al. (1996) for dietary con-
centrations of TEQs in fish to protect mink repro-
ductive health was 4.4 pg TEQ/g fish. Thus, based on
the potential for reproductive impairment and these
biomagnification factors, H4IIE cell bioassay values
in fish greater than 5 pg TCDD/g may be screened
as hazardous to avian and mammalian wildlife that
consume fish.
V. SUMMARY: ADVANCES AND
FUTURE DIRECTIONS FOR THE
H4IIE CELL BIOASSAY
The H4IIE cell bioassay has proven utility both
as a screening tool for dioxin-like chemicals in or-
ganisms from the wild, and as a means of estimating
the hazard posed to organisms exposed to PHHs.
This technique has several advantages over the an-
alytical measurement of PHHs in samples, but con-
clusions from studies can be strengthened when both
bioassay and analytical chemistry data are presented
together. Often, the bioassay results concur with bi-
ological effects in organisms and also support direct
measures of PHHs. For biomonitoring purposes and
prioritization of PHH-contaminated environments,
the H4IIE bioassay is faster and less expensive than
analytical measurements. The H4IIE cell bioassay
can be used in combination with other biomarkers
such as in vivo measurements of CYP1A1 induction
(Whyte et al., 2000a) to help pinpoint the sources
and identities of dioxin-like chemicals. The number
of studies that measure H4IIE-derived TCDD-EQs
continues to increase, resulting in subtle improve-
ments of the method and interpretation over time.
A. Reporter Gene Systems for
TCDD-EQ Determination in H4IIE
The development and distribution of recombi-
nant cell lines, including the H4IIE cells, that use a
luciferase reporter gene has also become increas-
ingly popular. Although the H4IIE cell bioassay
is widely used in research investigations, reason-
able concern exists over the difficulties discussed
in this review, such as inhibition of CYP1A1 ac-
tivity at high ligand concentrations and incom-
plete concentration-response curves. Measurement
of CYP1A1 protein rather than catalytic activity
has been suggested one way of dealing with these
problems (Hahn et al., 1996), but these methods
require greater time investments than the catalytic
assay. Recently, a recombinant H4IIE cell line has
been produced that contains a luciferase gene of
the firefly (Photinus pyralis) regulated by dioxin-
responsive elements upon interaction with the AhR
(Sanderson et al., 1996). Exposure of the cells
to AhR agonists activates the production of lu-
ciferase, which is quantified by measuring the light
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production after addition of the substrate luciferin
(Hamers et al., 2000). The increased expression of
luciferase is measured using a luminometer. The
cell line, named H4IIE-luc, is reported to be three-
fold more sensitive to TCDD than wild-type H4IIE
(Sanderson et al., 1996). This increased sensitiv-
ity of H4IIE-luc cells may allow full concentration-
response curves to be generated with lower con-
centrations of extract, avoiding cytotoxicity and
CYP1A1 inhibition seen in wild type cells at high
PHH concentrations. Hamers et al. (2000) state that
AhR activation in H4IIE-luc cells by easily metabo-
lized compounds such as PAHs can be distinguished
from the response to more persistent compounds
such as PHHs. PAH-induced luciferase production
can be measured 6 h after exposure, but is no longer
detectable after 24 h of exposure, presumably due
to metabolic breakdown of the inducers. For PHHs,
induction of luciferase is still present after 24 h and
longer. The cells are reported to yield stable EC50
values for TCDD over long periods of cell culture.
A recently described fluorescence-based cell
bioassay may offer methodological and cost advan-
tages over the H4IIE and H4IIE-luc bioassays. Nagy
et al. (2002a,b) describe the development and opti-
mization of a recombinant mouse hepatoma cell line
(Hepa1c1c7) that responds to AhR-agonists with
the induction of enhanced green fluorescent protein
(EGFP). The expressed EGFP fluoresces directly
without the need for additional reagents, allowing
rapid and inexpensive “real-time” measurement of
reporter gene activity. Such fluorescence-based as-
says need to be well characterized before they can
be used routinely for biomonitoring studies.
The wild-type H4IIE cell bioassay remains
more widely used than luciferase bioassays, at
present. Reasons for this include the extensive his-
torical use of the wild-type assay and the availability
of the recombinant cells. However, as the H4IIE-
luc continues to undergo adaptations, the technique
will likely gain in popularity. To date, the use of
H4IIE-luc in several field studies has been reported
(Murk et al., 1996; Khim et al., 2000; Hamers et al.,
2000; Hilscherova et al., 2000; Kannan et al., 2000;
Koppen et al., 2001).
B. Wise Use of the H4IIE
Cell Bioassay
The H4IIE cell bioassay can be a powerful ana-
lytical tool, but like all tools, it must be used for the
purposes it is intended and care must be exercised
to ensure reliable results. The H4IIE cell bioassay
can indicate the presence of AhR ligands, but not all
AhR ligands elicit the same toxic responses. Strong
relationships between toxicity and EROD induc-
tion in H4IIE cells resulting from dioxin, furan and
PCB exposure have been demonstrated (see Section
ID). Hazard assessments that include the use of the
H4IIE cell bioassay for these classes of compounds
are therefore justifiable. Insufficient evidence exists
that relates toxic responses and H4IIE TCDD-EQs
for compounds such as PAHs. For these chemical
classes, the H4IIE bioassay should only be used to
indicate contaminant exposure. As more data are
generated relating toxicity to responses in the H4IIE
cell bioassay, the potential for the use of this bioas-
say as a tool for hazard assessment will continue to
grow.
Further experiments are required to determine
if TCDD-EQs derived from the H4IIE cell bioassay
are the best predictors of toxicity to other species,
or if cultured cells should be related to the species
being examined (Lipp et al., 1992; Lee et al., 1993;
Lorenzen et al., 1997b). For instance, research in-
dicates that the structure–activity relationships for
PCBs could be more dependent on the species than
is the case for other PHHs (Gooch et al., 1989;
Stegeman and Hahn, 1993). However, in nonmam-
malian species, much less is known about the mech-
anism by which the AhR controls CYP1A induc-
tion (Hahn et al., 1993). The H4IIE cell bioassay
currently provides a clear indication of PHH ex-
posure, and while it does not account for possi-
ble differences in the relative toxicity of PHH con-
geners among species, this exposure estimate can
provide a rapid means of ranking environmental
samples (e.g., fish or avian tissue samples) accord-
ing to their TCDD-EQs. As research in the area of
taxon-specific differences in PHH structure–activity
relationships continues, the role of the H4IIE cell
line bioassay in predicting the relative hazard of
PHH exposure to different species will become more
clear. These challenges considered, the combination
of speed, simplicity, and ability to integrate the ef-
fects of complex contaminant mixtures makes the
H4IIE cell bioassay in its current state a valuable
addition to hazard assessment and biomonitoring
studies.
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